kidney
involv
wide
rang
bacteri
viral
fungal
parasit
diseas
system
infect
renal
involv
minor
compon
ill
renal
failur
may
present
featur
major
problem
manag
although
individu
infecti
process
may
predilect
involv
renal
vasculatur
glomeruli
interstitium
collect
system
pure
anatom
approach
classif
infecti
diseas
affect
kidney
rare
help
infect
may
involv
sever
differ
aspect
renal
function
chapter
microbiolog
classif
organ
affect
kidney
adopt
although
import
caus
renal
dysfunct
infecti
diseas
urinari
tract
infect
hemolyt
urem
syndrom
hu
discuss
detail
consid
separ
chap
renal
involv
children
hu
urinari
tract
infect
children
respect
elucid
caus
renal
involv
child
evid
infect
must
base
care
consider
geograph
distribut
infecti
diseas
differ
countri
histori
foreign
travel
exposur
anim
insect
unusu
food
drink
outdoor
activ
swim
hike
contact
infecti
diseas
must
sought
everi
case
clinic
examin
includ
care
assess
skin
mucou
membran
search
insect
bite
lymphadenopathi
involv
organ
close
collabor
pediatr
infecti
diseas
specialist
hospit
microbiologist
aid
diagnosi
manag
underli
infect
tantal
clue
pathogenesi
glomerular
diseas
mark
differ
incid
nephrosi
nephriti
develop
underdevelop
area
world
sever
tropic
countri
glomerulonephr
gn
account
pediatr
hospit
admiss
incid
temper
climat
less
differ
might
explain
complex
interact
sever
differ
factor
includ
nutrit
racial
genet
determin
differ
immun
respons
exposur
infecti
diseas
grow
bodi
evid
howev
suggest
longterm
exposur
infecti
agent
major
factor
increas
preval
glomerular
diseas
develop
countri
renal
involv
infecti
diseas
may
occur
varieti
mechan
direct
microbi
invas
renal
tissu
collect
system
may
take
place
condit
staphylococc
abscess
kidney
occur
result
septicem
spread
organ
ascend
infect
commonli
occur
due
infect
urinari
tract
damag
kidney
may
caus
system
releas
endotoxin
toxin
activ
inflammatori
cascad
septicemia
due
focu
infect
distant
kidney
ischem
damag
may
result
inadequ
perfus
induc
septic
shock
kidney
may
damag
activ
immunolog
pathway
immun
complex
result
infecti
process
mani
condit
combin
mechan
may
oper
assess
renal
complic
occur
infecti
diseas
possibl
druginduc
nephrotox
caus
antimicrobi
therapi
alway
consid
nephrotox
effect
antibiot
antimicrobi
agent
address
chapter
cover
chap
handl
drug
children
abnorm
renal
function
bacteri
infect
associ
renal
diseas
like
mechan
caus
renal
dysfunct
shown
tabl
impair
renal
function
common
system
sepsi
acut
kidney
injuri
aki
independ
risk
factor
mortal
pediatr
sepsi
depend
sever
infect
organ
respons
renal
involv
may
vari
insignific
proteinuria
aki
requir
dialysi
organ
caus
aki
part
system
sepsi
vari
age
geograph
locat
also
differ
normal
immunocompromis
children
neonat
period
group
b
streptococci
coliform
staphylococcu
aureu
listeria
monocytogen
organ
usual
respons
older
children
neisseria
meningitidi
streptococcu
pneumonia
group
streptococcu
staphylococcu
aureu
account
infect
peopl
immunocompromis
wide
rang
bacteria
seen
similarli
tropic
countri
pathogen
includ
haemophilu
influenza
salmonella
speci
pseudomona
pseudomallei
must
consid
vaccin
n
meningitid
pneumonia
h
influenza
reduc
impact
infect
uptak
vari
differ
countri
system
sepsi
usual
present
nonspecif
featur
fever
tachypnea
tachycardia
evid
skin
organ
underperfus
pathophysiolog
renal
involv
system
sepsi
multifactori
hypovolemia
diminish
renal
perfus
earliest
event
consequ
increas
vascular
permeabl
loss
plasma
intravascular
space
hypovolemia
commonli
coexist
depress
myocardi
function
myocardi
depress
effect
endotoxin
toxin
renal
vasoconstrictor
respons
diminish
circul
volum
reduc
cardiac
output
reduc
glomerular
filtrat
oliguria
thu
consist
earli
event
sever
sepsi
number
vasodil
pathway
activ
sepsi
includ
nitric
oxid
kinin
pathway
may
lead
inappropri
dilat
vascular
bed
vasodilat
capillari
bed
lead
warm
shock
common
adult
sepsi
due
gramneg
organ
less
commonli
seen
children
intens
vasoconstrict
usual
respons
sepsi
renal
underperfus
vasoconstrict
persist
sever
revers
preren
failur
follow
establish
renal
failur
characterist
featur
vasomotor
nephropathi
acut
tubular
necrosi
mechan
renal
damag
system
sepsi
includ
direct
effect
endotoxin
toxin
kidney
releas
inflammatori
mediat
tumor
necrosi
factor
tnf
cytokin
arachidon
acid
metabolit
proteolyt
enzym
leukocyteendotheli
interact
result
physic
congest
medullari
vasculatur
decreas
region
blood
flow
nitric
oxid
postul
play
key
role
pathophysiolog
renal
failur
sepsi
produc
three
cellspecif
nitric
oxid
synthas
no
isoform
within
kidney
endotheli
no
eno
express
endotheli
cell
play
role
vascular
relax
inhibit
leukocyt
adhes
platelet
aggreg
endotheli
injuri
renal
ischemia
report
impair
product
eno
induc
no
ino
implic
import
mediat
vasodilat
upregul
within
medulla
glomeruli
sepsi
alter
no
express
product
within
system
circul
kidney
support
extens
test
no
inhibitor
sepsi
renal
ischemia
trial
select
synthas
inhibit
offer
advantag
salin
resuscit
activ
coagul
import
compon
pathophysiolog
septic
shock
contribut
intraglomerular
thrombosi
tubular
injuri
lead
cell
detach
intratubular
obstruct
tubular
backleak
recoveri
necessit
clearanc
necrot
cell
debri
well
repair
nonfat
injur
cell
activ
multipl
prothrombot
antifibrinolyt
pathway
occur
togeth
downregul
antithrombot
mechan
protein
c
pathway
treatment
activ
protein
c
shown
improv
outcom
adult
septic
shock
confirm
benefit
pediatr
sepsi
may
carri
risk
bleed
particularli
infant
renal
find
earli
septic
shock
oliguria
high
urineplasma
urea
creatinin
ratio
low
urin
sodium
concentr
high
urineplasma
osmolar
ratio
establish
renal
failur
superven
urin
poor
qualiti
low
urineplasma
urea
creatinin
ratio
elev
urin
sodium
concentr
low
urin
osmolar
proteinuria
usual
present
urin
sediment
may
contain
red
cell
small
number
white
cell
manag
aki
system
sepsi
depend
earli
diagnosi
administr
appropri
antibiot
cover
expect
pathogen
relianc
creatinin
urin
output
identifi
aki
use
eg
pediatr
rifl
score
may
futur
improv
use
altern
biomark
neutrophil
gelatinaseassoci
lipocalin
ngal
manag
direct
improv
renal
perfus
oxygen
volum
replac
crystalloid
colloid
undertaken
optim
preload
central
venou
pressur
pulmonari
wedg
pressur
monitor
essenti
guid
volum
replac
children
sever
shock
use
lowdos
pgkgmin
dopamin
reduc
renal
vasoconstrict
togeth
administr
inotrop
agent
dobutamin
epinephrin
improv
cardiac
output
may
revers
preren
failur
earli
elect
ventil
undertaken
patient
sever
shock
oliguria
persist
despit
volum
replac
inotrop
therapi
dialysi
hemofiltr
institut
earli
septic
catabol
patient
may
rapidli
develop
hyperkalemia
sever
electrolyt
imbal
children
develop
aki
part
system
sepsi
septic
shock
renal
failur
short
durat
recoveri
expect
within
day
achiev
cardiovascular
stabil
erad
underli
infect
occasion
renal
cortic
necrosi
infarct
kidney
may
result
prolong
perman
loss
renal
function
neisseria
meningitidi
continu
major
caus
system
sepsi
mening
develop
underdevelop
part
world
develop
countri
case
caus
group
b
strain
particularli
introduct
meningococc
c
vaccin
wherea
epidem
meningococc
group
c
continu
occur
mani
underdevelop
region
world
meningococc
b
vaccin
approv
use
europ
canada
australia
use
unit
state
help
control
outbreak
see
www
meningitisorgmenbvaccin
peak
incid
infant
group
b
diseas
teenag
young
adult
group
c
howev
diseas
occur
age
two
major
present
meningococc
diseas
meningococc
mening
present
featur
indistinguish
form
mening
includ
headach
stiff
neck
photophobia
lumbar
punctur
requir
identifi
caus
agent
distinguish
form
mening
despit
acut
natur
ill
prognosi
good
patient
pure
meningit
form
ill
recov
without
sequela
common
sequela
hear
loss
children
hear
test
discharg
meningococcemia
purpur
rash
shock
second
devast
form
ill
affect
patient
present
nonspecif
symptom
fever
vomit
abdomin
pain
muscl
ach
diagnosi
obviou
characterist
petechi
purpur
rash
appear
patient
rapidli
progress
purpur
rash
hypotens
evid
skin
organ
underperfus
poor
prognosi
mortal
advers
prognost
featur
includ
hypotens
low
white
cell
count
absenc
mening
inflamm
thrombocytopenia
disturb
coagul
indic
combin
renal
failur
seldom
report
earli
seri
patient
meningococcemia
perhap
patient
die
rapidli
uncontrol
septic
shock
advanc
intens
care
howev
children
surviv
initi
period
profound
hemodynam
derang
renal
failur
often
seen
major
manag
problem
children
fulmin
sepsi
particularli
gramneg
organ
includ
n
meningitidi
develop
renal
failur
associ
rhabdomyolysi
pathophysiolog
meningococc
septicemia
involv
activ
cytokin
inflammatori
cell
endotoxin
mortal
directli
relat
plasma
endotoxin
concentr
intens
inflammatori
respons
indic
level
tnf
inflammatori
marker
patient
meningococcemia
profound
capillari
leak
lead
sever
hypovolemia
loss
plasma
protein
intravascular
space
probabl
major
caus
shock
myocardi
suppress
secondari
product
also
import
intens
vasoconstrict
impair
tissu
organ
perfus
vascul
intravascular
thrombosi
consumpt
platelet
coagul
factor
also
present
oliguria
invari
present
children
meningococcemia
initi
phase
disord
preren
origin
may
respond
volum
replac
inotrop
support
cardiac
output
improv
renal
underperfus
persist
establish
renal
failur
superven
occasion
cortic
necrosi
infarct
kidney
occur
children
meningococcemia
aggress
manag
pediatr
intens
care
unit
earli
administr
antibiot
penicillin
thirdgener
cephalosporin
volum
replac
hemodynam
monitor
use
inotrop
agent
vasodil
oliguria
persist
despit
measur
improv
cardiac
output
elect
ventil
dialysi
institut
earli
activ
coagul
pathway
occur
sever
acquir
protein
c
defici
may
result
usual
associ
substanti
mortal
protein
c
natur
anticoagul
also
import
antiinflammatori
activ
despit
evid
impair
function
activ
protein
c
pathway
meningococc
diseas
adult
trial
suggest
benefit
activ
protein
c
administr
septic
shock
prowess
trial
pediatr
trial
activ
protein
c
show
clear
benefit
associ
increas
risk
intracrani
bleed
young
infant
role
apc
therapi
pediatr
sepsi
remain
unclear
patient
surviv
initi
h
ill
regain
hemodynam
stabil
ultim
recov
renal
function
even
dialysi
requir
sever
week
least
common
present
meningococc
sepsi
chronic
meningococcemia
patient
form
ill
present
insidi
vasculit
rash
arthriti
evid
multiorgan
involv
featur
may
overlap
henochschonlein
purpura
subacut
bacteri
endocard
sbe
diagnosi
must
consid
patient
present
fever
arthriti
vasculit
rash
often
accompani
proteinuria
hematuria
respons
antibiot
treatment
good
patient
may
persist
symptom
mani
day
result
immunecomplex
vascul
staphylococc
infect
may
affect
kidney
direct
focal
invas
staphylococc
septicemia
form
renal
abscess
caus
staphylococc
bacteremia
toxinmedi
mechan
staphylococc
toxic
shock
syndrom
staphylococc
abscess
staphylococc
renal
abscess
present
fever
loin
pain
tender
abnorm
urin
sediment
abscess
caus
organ
ill
often
follow
either
septicemia
pyelonephr
diagnosi
usual
consid
patient
clinic
pyelonephr
show
inadequ
respons
antibiot
treatment
diagnosi
confirm
ultrasonographi
comput
tomograph
scan
show
swell
kidney
intraren
collect
fluid
antibiot
therapi
alon
may
result
cure
empir
therapi
cover
gramposit
gramneg
organ
microbiolog
diagnosi
achiev
treatment
may
requir
percutan
drainag
alongsid
antibiot
therapi
may
need
persist
week
open
drainag
may
necessari
approach
fail
staphylococc
toxic
shock
syndrom
staphylococc
toxic
shock
syndrom
system
ill
character
fever
shock
erythemat
rash
diarrhea
confus
renal
failur
disord
first
describ
todd
et
al
seri
seven
children
thousand
case
report
unit
state
case
menstruat
women
associ
tampon
use
menstrual
nonmenstru
case
equal
common
includ
children
sex
age
ill
usual
begin
suddenli
high
fever
diarrhea
confus
hypotens
togeth
diffus
erythroderma
mucou
membran
involv
hyperemia
ulcer
lip
oral
mucosa
vagin
mucosa
strawberri
tongu
conjunctiv
inject
usual
seen
desquam
rash
occur
convalesc
phase
ill
confus
often
present
earli
stage
ill
may
progress
coma
sever
case
multipl
organ
failur
evid
impair
renal
function
elev
level
hepat
transaminas
thrombocytopenia
elev
cpk
dissemin
intravascular
coagul
dic
often
seen
accord
cdc
criteria
diagnosi
made
basi
clinic
featur
fever
rash
hypotens
subsequ
desquam
along
derang
function
three
follow
organ
system
gastrointestin
gi
mucou
membran
renal
hepat
hematolog
central
nervou
system
muscl
disord
caus
similar
pictur
rocki
mountain
spot
fever
leptospirosi
measl
streptococc
infect
must
exclud
staphylococc
toxic
shock
syndrom
caus
infect
colon
strain
aureu
produc
one
protein
exotoxin
case
adult
associ
toxic
shock
toxin
children
mani
isol
associ
syndrom
produc
enterotoxin
f
staphylococc
enterotoxin
induc
diseas
act
superantigen
activ
cell
bear
specif
v
beta
region
tcell
receptor
caus
prolifer
cytokin
releas
system
ill
toxic
believ
result
larg
intens
inflammatori
respons
induc
toxin
site
toxin
product
often
trivial
focu
infect
simpl
colon
bacteremia
rare
observ
renal
failur
toxic
shock
syndrom
usual
caus
shock
renal
hypoperfus
earli
stage
ill
oliguria
renal
impair
usual
preren
respond
treatment
shock
measur
improv
perfus
sever
case
patient
treatment
delay
aki
develop
consequ
prolong
renal
underperfus
dialysi
may
requir
addit
underperfus
direct
effect
toxin
inflammatori
mediat
may
also
contribut
renal
damag
recoveri
renal
function
usual
occur
sever
case
cortic
necrosi
intens
renal
vascul
prolong
dialysi
may
requir
manag
staphylococc
toxic
shock
syndrom
depend
earli
diagnosi
aggress
cardiovascular
support
volum
replac
inotrop
support
sever
case
elect
ventil
oliguria
persist
despit
optim
intravascular
volum
administr
inotrop
agent
dialysi
commenc
earli
antistaphylococc
antibiot
start
soon
diagnosi
suspect
site
infect
identifi
current
advic
red
book
http
aapredbookaappubl
org
initi
empir
antimicrobi
therapi
includ
antistaphylococc
antibiot
effect
betalactamaseresist
organ
protein
synthesisinhibit
antibiot
clindamycin
stop
toxin
product
focu
infect
vagin
tampon
surgic
wound
infect
sinus
site
drain
earli
prevent
continu
toxin
releas
circul
intraven
administr
immunoglobulin
may
consid
infect
refractori
sever
hour
aggress
therapi
undrain
focu
present
persist
oliguria
pulmonari
edema
occur
aggress
intens
care
affect
patient
surviv
renal
recoveri
usual
even
patient
sever
shock
multiorgan
failur
relaps
recurr
staphylococc
toxic
shock
syndrom
occur
proport
affect
patient
immun
respons
toxin
ineffect
individu
pantonvalentin
leukocidin
pvl
produc
staphylococc
infect
recent
year
increas
report
sever
staphylococc
diseas
associ
shock
multiorgan
failur
caus
strain
staphylococci
produc
pvl
toxin
pantonvalentin
leukocidin
pvl
phageencod
toxin
profoundli
impair
host
respons
due
toxic
effect
leukocyt
see
review
pvlproduc
strain
associ
tissu
necrosi
increas
propens
caus
abscess
lung
bone
joint
soft
tissu
infect
perinephr
abscess
report
increas
number
children
adult
admit
fulmin
sepsi
shock
due
pvlproduc
strain
renal
failur
signific
compon
multiorgan
failur
addit
intens
care
support
antibiot
treatment
pvl
strain
includ
antibiot
reduc
toxin
product
clindamycin
linezolid
rifampicin
well
vancomycin
strain
resist
methicillin
betalactam
antibiot
avoid
data
suggest
pvl
toxin
product
increas
antibiot
condit
immunoglobulin
infus
may
also
benefit
pvl
sepsi
often
associ
thrombosi
prophylact
heparin
commenc
serious
ill
patient
aggress
surgic
drainag
collect
requir
close
consult
orthoped
surgic
team
group
streptococci
ga
extracellular
gramposit
organ
major
worldwid
caus
renal
diseas
usual
poststreptococc
nephriti
howev
addit
postinfect
immunolog
mediat
disord
ga
caus
aki
part
invas
infect
mani
featur
staphylococc
toxic
shock
syndrom
acut
poststreptococc
glomerulonephr
acut
poststreptococc
gn
apsgn
delay
complic
pharyng
infect
impetigo
certain
nephritogen
strain
ga
though
mani
case
postinfecti
gn
unrel
streptococcu
worldwid
incid
apsgn
decreas
although
cluster
case
continu
occur
apsgn
pharyng
infect
associ
differ
serotyp
compar
pyoderma
skin
infect
differ
strain
serotyp
accord
antigen
properti
protein
found
outer
portion
bacteri
wall
patholog
pathogenesi
disord
discuss
detail
chap
acut
postinfecti
glomerulonephr
children
detect
ga
patient
apsgn
may
possibl
cultur
skin
throat
patient
evid
infect
ga
obtain
antistreptolysino
titer
asot
increas
case
earli
antibiot
treatment
reduc
proport
case
elev
asot
antideoxyribonucleas
b
antihyaluronidas
test
shown
valu
asot
confirm
group
streptococc
infect
impetigoassoci
case
decreas
total
hemolyt
complement
level
found
case
first
week
ill
return
normal
week
penicillin
given
erad
ga
organ
erythromycin
clindamycin
firstgener
cephalosporin
given
patient
allerg
penicillin
earli
antibiot
therapi
help
prevent
immun
respons
streptococc
antigen
thu
progress
glomerulonephr
rheumat
fever
sequela
treatment
failur
thought
due
coexist
betalactamaseproduc
bacteria
tonsillopharynx
due
streptococci
invad
epitheli
cell
protect
antibiot
instanc
amoxicillin
given
clavulan
close
contact
famili
member
cultureposit
ga
also
given
penicillin
although
antibiot
treatment
alway
effect
elimin
secondari
case
recurr
episod
rare
immun
particular
nephritogen
strain
caus
diseas
probabl
lifelong
antibiot
prophylaxi
therefor
unnecessari
studi
suggest
prognosi
children
apsgn
good
make
complet
recoveri
howev
case
may
prolong
seriou
cours
longterm
chronic
renal
failur
streptococci
apsgn
also
describ
outbreak
group
c
streptococc
infect
exampl
streptococcu
equi
subsp
zooepidemicu
found
respons
larg
epidem
south
america
group
c
streptococc
infect
occur
consumpt
unpasteur
milk
cattl
mastiti
patient
develop
pharyng
follow
apsgn
endostreptosin
found
cytoplasm
group
c
strain
cours
ill
patient
develop
antiendostreptosin
antibodi
antigen
postul
nephritogen
compon
ga
addit
strain
group
g
streptococci
implic
occasion
case
apsgn
isol
possess
type
protein
antigen
ident
nephritogen
type
antigen
group
streptococc
strain
streptococc
toxic
shock
syndrom
invas
group
streptococc
infect
group
streptococcu
caus
sever
ill
similar
staphylococc
toxic
shock
syndrom
occur
children
adult
associ
invas
group
streptococc
diseas
patient
syndrom
present
acut
high
fever
erythemat
rash
mucou
membran
involv
hypotens
multiorgan
failur
unlik
staphylococc
toxic
shock
syndrom
focu
infect
usual
trivial
bacteremia
seldom
seen
streptococc
toxic
shock
syndrom
usual
associ
bacteremia
seriou
focu
infect
septic
arthriti
myositi
osteomyel
laboratori
find
anemia
neutrophil
leukocytosi
thrombocytopenia
dic
often
present
togeth
impair
renal
function
hepat
derang
acidosi
aki
requir
dialysi
occur
signific
proport
case
clear
increas
number
case
invas
diseas
caus
ga
emerg
streptococc
toxic
shock
syndrom
inde
similar
syndrom
caus
pseudomona
klebsiella
strain
common
anteced
invas
ga
diseas
varicella
infect
streptococc
infect
develop
initi
vesicular
phase
diseas
subsid
strain
caus
toxic
shock
syndrom
invas
diseas
appear
differ
common
isol
ga
produc
larg
amount
pyrogen
toxin
may
superantigenlik
activ
anoth
import
mechan
product
invas
ga
proteas
serv
molecular
bridg
receptor
neutrophil
vascular
endothelium
cleavag
protein
prevent
neutrophil
attach
endothelium
result
uncontrol
spread
bacteria
tissu
sever
case
necrot
fasciiti
occur
extens
destruct
subcutan
tissu
often
associ
multiorgan
failur
pathophysiolog
streptococc
toxic
shock
syndrom
invas
diseas
similar
superantigen
toxin
induc
releas
cytokin
inflammatori
mediat
play
role
condit
howev
ga
toxic
shock
usual
sever
carri
higher
mortal
often
associ
focal
collect
necrot
fasciiti
treatment
streptococc
toxic
shock
syndrom
depend
administr
appropri
antibiot
aggress
circulatori
support
treatment
multiorgan
failur
surgic
intervent
drain
infect
focu
muscl
bone
joint
bodi
caviti
often
requir
antibiot
therapi
betalactam
supplement
treatment
protein
synthesisinhibit
antibiot
clindamycin
suggest
limit
new
toxin
product
pool
intraven
immunoglobulin
widespread
use
treatment
toxic
shock
particularli
caus
streptococcu
though
studi
report
benefit
prospect
observ
studi
suggest
concomit
use
immunoglobulin
clindamycin
posit
synergist
effect
mortal
role
steroid
remain
unclear
hemodynam
benefit
set
detriment
effect
hyperglycemia
secondari
gluconeogenesi
benefit
insulin
therapi
control
hyperglycemia
unclear
studi
adult
found
intens
insulin
therapi
increas
risk
seriou
advers
event
contrast
adult
patient
children
sever
sepsi
use
activ
protein
c
drotrecogin
recommend
multicent
trial
fatal
increas
treatment
group
recoveri
renal
function
occur
patient
respond
treatment
shock
erad
infect
infect
pneumonia
one
common
infect
human
caus
wide
spectrum
diseas
includ
pneumonia
otiti
media
sinus
septicemia
mening
despit
preval
organ
signific
renal
involv
rel
rare
seen
two
situat
pneumococc
septicemia
asplen
individu
immunodefici
present
fulmin
septic
shock
renal
failur
may
occur
part
multisystem
derang
mortal
pneumococc
sepsi
asplen
patient
high
even
earli
antibiot
treatment
intens
support
second
nephrolog
syndrom
associ
pneumonia
rare
form
hu
account
hu
case
children
typic
develop
day
streptococc
infect
incid
follow
streptococc
infect
sinc
introduct
vaccin
report
hu
case
caus
strain
cover
vaccin
gasser
colleagu
describ
hu
clinic
entiti
children
includ
two
infant
pneumonia
among
five
patient
describ
hu
associ
pneumococc
infect
differ
pathophysiolog
caus
common
vero
toxinproduc
e
coli
pneumonia
well
influenza
clostridia
speci
produc
enzym
neuraminidas
cleav
sialic
acid
surfac
expos
cell
neuraminidas
caus
desial
red
blood
cell
possibl
blood
cell
endothelium
remov
termin
neuramin
acid
lead
unmask
thomsenfriedenreich
antigen
antigen
present
surfac
red
blood
cell
platelet
glomerular
capillari
endothelia
normal
serum
contain
antibodi
antigen
caus
widespread
agglutin
blood
cell
platelet
antigen
expos
result
intravascular
obstruct
hemolysi
thrombocytopenia
renal
failur
direct
coomb
test
posit
case
streptococc
hu
either
bound
antit
igm
antit
antibodi
diagnosi
thomsenfriedenreich
antibodyinduc
hu
suspect
patient
aki
thrombocytopenia
hemolysi
episod
pneumonia
bacteremia
caus
pneumonia
fragment
red
blood
cell
usual
present
blood
film
associ
hu
pneumonia
defin
cultur
pneumococci
normal
steril
site
within
week
onset
sign
hu
clue
pneumococc
caus
addit
cultur
result
includ
sever
clinic
diseas
especi
pneumonia
empyema
pleural
effus
mening
hemolyt
anemia
posit
result
direct
coomb
test
difficulti
abo
crossmatch
posit
minor
crossmatch
incompat
howev
renal
diseas
seen
context
sever
pneumococc
infect
import
maintain
broad
diagnost
perspect
frequenc
acut
tubular
necrosi
septic
shock
dic
therapi
syndrom
support
treatment
antibiot
usual
thirdgener
cephalosporin
dialysi
may
requir
renal
failur
occur
normal
serum
contain
antibodi
thomsenfriedenreich
antigen
blood
transfus
undertaken
wash
red
blood
cell
resuspend
albumin
rather
plasma
exchang
transfus
plasmapheresi
use
patient
rational
procedur
may
improv
outcom
elimin
circul
neuraminidas
intraven
igg
use
patient
shown
neutral
neuraminidas
present
patient
serum
comparison
patient
common
diarrheaassoci
hu
pneumoniaeinduc
hu
patient
sever
renal
diseas
like
requir
dialysi
longterm
outcom
may
affect
sever
invas
streptococc
diseas
signific
proport
surviv
patient
develop
endstag
renal
failur
review
uk
case
found
eightfold
increas
earli
mortal
compar
diarrheainduc
hu
fresh
frozen
plasma
avoid
unless
activ
bleed
concern
preform
antitf
antibodi
present
ffp
leptospirosi
acut
gener
infecti
diseas
caus
spirochet
genu
leptospira
primarili
diseas
wild
domest
anim
human
infect
occasion
contact
anim
human
case
occur
summer
autumn
associ
exposur
leptospiracontamin
water
soil
recreat
activ
swim
camp
adolesc
adult
occup
exposur
farm
contact
anim
rout
infect
spirochet
penetr
intact
mucou
membran
abrad
skin
dissemin
part
bodi
includ
cerebrospin
fluid
csf
although
leptospira
contain
classic
endotoxin
pathophysiolog
disord
mani
similar
endotoxemia
sever
case
jaundic
occur
hepatocellular
dysfunct
cholestasi
renal
function
abnorm
may
profound
proport
histolog
chang
kidney
renal
involv
predominantli
result
tubular
damag
spirochet
commonli
seen
tubular
lesion
inflammatori
chang
kidney
may
result
either
direct
toxic
effect
organ
immunecomplex
nephriti
howev
hypovolemia
hypotens
reduc
cardiac
output
caus
myocard
may
contribut
develop
renal
failur
sever
case
hemorrhag
disord
caus
widespread
vascul
capillari
injuri
also
occur
clinic
manifest
leptospirosi
variabl
affect
patient
milder
anicter
form
disord
sever
leptospirosi
jaundic
ill
may
follow
biphas
cours
incub
period
day
nonspecif
flulik
ill
last
day
occur
associ
septicem
spread
spirochet
fever
subsid
recur
second
immun
phase
ill
phase
fever
low
grade
may
headach
delirium
caus
mening
involv
well
intens
muscular
ach
nausea
vomit
common
examin
usual
reveal
conjunctiv
suffus
erythemat
rash
lymphadenopathi
mening
sever
form
diseas
weil
diseas
present
fever
impair
renal
hepat
function
hemorrhag
vascular
collaps
alter
conscious
one
seri
common
organ
involv
liver
kidney
cardiovascular
pulmonari
neurolog
hematolog
involv
less
common
vascul
thrombocytopenia
uremia
consid
import
factor
pathogenesi
hemorrhag
disturb
main
caus
death
sever
leptospirosi
urinalysi
result
abnorm
leptospirem
phase
proteinuria
hematuria
cast
uremia
usual
appear
second
week
aki
may
develop
cardiovascular
collaps
dic
present
clinic
featur
leptospirosi
overlap
sever
acut
infecti
diseas
includ
rocki
mountain
spot
fever
toxic
shock
syndrom
streptococc
sepsi
diagnosi
leptospirosi
consid
febril
patient
evid
renal
hepat
mucou
membran
chang
rash
particularli
histori
exposur
freshwat
found
diagnosi
confirm
isol
spirochet
blood
csf
first
day
ill
urin
second
week
organ
may
seen
biopsi
specimen
kidney
skin
csf
darkfield
microscopi
silver
stain
serolog
test
detect
leptospirosi
sensit
consider
aid
diagnosi
immunoglobulin
igm
antibodi
may
detect
earli
day
ill
antibodi
titer
rise
progress
next
week
patient
remain
seroneg
neg
serolog
test
result
complet
exclud
diagnosi
one
seri
level
igm
igg
anticardiolipin
concentr
significantli
increas
leptospirosi
patient
aki
leptospirosi
treat
intraven
penicillin
betalactam
antibiot
sever
leptospirosi
reduc
antibiot
treatment
even
start
late
cours
ill
support
treatment
volum
replac
correct
hypovolemia
administr
inotrop
correct
coagulopathi
essenti
sever
case
dialysi
may
requir
sever
case
may
need
prolong
period
recoveri
occur
diarrheal
diseas
caus
escherichia
coli
salmonella
shigella
campylobact
vibrio
spp
yersinia
remain
import
common
bacteri
infect
human
although
improv
hygien
live
condit
reduc
incid
bacteri
gastroenter
develop
countri
infect
remain
common
underdevelop
area
world
outbreak
epidem
continu
occur
develop
underdevelop
countri
renal
involv
enter
infect
may
result
four
possibl
mechan
sever
diarrhea
dehydr
regardless
caus
organ
diarrhea
result
hypovolemia
abnorm
plasma
electrolyt
composit
renal
underperfus
sever
dehydr
occur
persist
oliguria
preren
failur
follow
vasomotor
nephropathi
establish
renal
failur
system
sepsi
endotoxemia
e
coli
shigella
salmonella
particularli
salmonella
typhi
may
invad
bloodstream
induc
septicemia
septic
shock
aki
commonli
seen
infant
e
coli
sepsi
also
report
klebsiella
salmonella
shigella
infect
pathophysiolog
treatment
discuss
previous
enter
pathogenassoci
nephriti
enter
infect
e
coli
yersinia
campylobact
salmonella
associ
sever
differ
form
gn
includ
membranoprolif
gn
mpgn
interstiti
nephriti
diffus
prolif
gn
iga
nephropathi
typhoid
fever
gn
rang
mild
asymptomat
proteinuria
hematuria
aki
may
occur
renal
biopsi
find
show
focal
prolifer
mesangi
cell
hypertrophi
endotheli
cell
congest
capillari
lumina
immunofluoresc
studi
show
igm
igg
deposit
glomeruli
salmonella
antigen
detect
within
granular
deposit
mesangi
area
iga
nephropathi
typhoid
fever
salmonella
vi
antigen
demonstr
within
glomeruli
yersinia
infect
report
precipit
gn
transient
proteinuria
hematuria
found
patient
acut
yersinia
infect
elev
creatinin
level
renal
biopsi
reveal
mild
mesangi
gn
iga
nephropathi
yersinia
antigen
immunoglobulin
complement
detect
glomeruli
yersinia
pseudotuberculosi
well
recogn
one
caus
acut
tubulointerstiti
nephriti
caus
aki
especi
children
patient
histori
drink
untreat
water
endem
area
ill
begin
sudden
onset
high
fever
skin
rash
gi
symptom
later
cours
periungu
desquam
develop
mimick
kawasaki
diseas
elev
erythrocyt
sediment
rate
creactiv
protein
level
thrombocytosi
notic
mild
degre
proteinuria
glycosuria
steril
pyuria
common
aki
typic
develop
week
onset
fever
follow
benign
cours
complet
recoveri
renal
biopsi
mainli
reveal
find
acut
tubulointerstiti
nephriti
antibiot
therapi
although
recommend
alter
clinic
cours
reduc
fecal
excret
organ
enter
pathogeninduc
hemolyt
urem
syndrom
hu
character
three
distinct
clinic
sign
aki
thrombocytopenia
microangiopath
hemolyt
anemia
first
describ
associ
infect
shiga
toxinproduc
shigella
dysenteria
major
breakthrough
search
caus
hu
occur
karmali
et
al
report
children
diarrheaassoci
hu
evid
infect
strain
e
coli
produc
toxin
activ
vero
cell
diarrheaassoci
hu
unit
state
europ
e
coli
import
strain
e
coli
occur
natur
gi
tract
cattl
anim
human
becom
infect
contamin
food
product
outbreak
associ
consumpt
undercook
meat
unpasteur
milk
cider
drink
water
poorli
chlorin
water
recreat
use
also
implic
vehicl
bacteri
spread
hu
discuss
detail
chap
renal
involv
children
hu
global
epidem
mycobacterium
tuberculosi
persist
sever
factor
contribut
includ
emerg
human
immunodefici
viru
hiv
infect
epidem
larg
influx
immigr
countri
tuberculosi
tb
common
emerg
multipledrugresist
tuberculosi
breakdown
health
servic
effect
control
tb
variou
countri
world
health
organ
estim
million
incid
case
tuberculosi
tb
world
rate
per
popul
tuberculosi
death
estim
million
onethird
world
popul
current
infect
tb
estim
lifetim
risk
develop
diseas
http
www
mycobacteria
tuberculosi
atyp
mycobacteria
also
emerg
import
caus
opportunist
infect
immunocompromis
patient
undergo
dialysi
patient
undergo
renal
transplant
possibl
mycobacteri
diseas
must
consid
patient
fever
unknown
origin
unexplain
diseas
lung
organ
result
mantoux
test
often
neg
diagnosi
depend
maintain
high
index
suspicion
isol
organ
infect
site
primari
progress
tb
although
infect
children
success
contain
infect
enter
state
latenc
develop
progress
primari
postprimari
infect
mycobacteria
dissemin
mani
organ
bodi
lymphohematogen
phase
diseas
tubercl
bacilli
recov
urin
mani
case
miliari
tb
hematogen
spread
tuberculomata
develop
glomeruli
result
caseat
slough
lesion
discharg
bacilli
tubul
case
renal
lesion
asymptomat
manifest
mycobacteria
urin
steril
pyuria
tuberculomata
cortex
may
calcifi
cavit
may
ruptur
pelvi
discharg
infect
organ
tubul
urethra
bladder
dysuria
loin
pain
hematuria
pyuria
present
featur
complic
mani
case
renal
involv
asymptomat
even
radiolog
patholog
abnorm
extens
continu
tubercul
bacilluria
may
caus
cystiti
urinari
frequenc
late
case
contract
bladder
intraven
urogram
abnorm
case
earli
find
pyelonephr
calyc
blunt
calycealinterstiti
reflux
later
papillari
caviti
may
seen
indic
papillari
necrosi
ureter
strictur
focal
calcif
hydronephrosi
cavit
may
also
seen
renal
function
usual
well
preserv
hypertens
uncommon
case
either
infect
reaction
chemotherapeut
agent
may
result
renal
failur
evid
interstiti
nephriti
renal
tb
classic
symptomat
renal
tb
late
uncommon
complic
children
averag
latenc
period
pulmonari
infect
bacillemia
clinic
urogenit
tuberculosi
year
renal
tb
commonli
seen
adult
adult
studi
shown
renal
tb
coexist
activ
pulmonari
tb
screen
sputumposit
pulmonari
tb
patient
renal
involv
diagnosi
establish
isol
mycobacteria
urin
presenc
characterist
clinic
radiograph
featur
child
current
previou
tb
renal
tb
treat
drug
regimen
similar
use
form
tb
isoniazid
rifampicin
pyrazinamid
ethambutol
administ
initi
month
isoniazid
rifampicin
continu
month
late
scar
urinari
obstruct
may
occur
case
extens
renal
involv
patient
follow
ultrasonographi
intraven
urogram
surgic
intervent
may
requir
form
stent
percutan
nephrostomi
partial
total
nephrectomi
renal
involv
congenit
acquir
syphili
estim
occurr
patient
secondari
syphili
congenit
syphili
common
manifest
renal
diseas
congenit
syphili
nephrot
syndrom
proteinuria
hypoalbuminemia
edema
patient
hematuria
uremia
hypertens
may
seen
renal
diseas
usual
associ
manifest
congenit
syphili
includ
hepatosplenomegali
rash
mucou
membran
find
nephriti
congenit
syphili
usual
associ
evid
complement
activ
depress
level
clq
histolog
find
diffus
prolif
gn
membran
nephropathi
interstitium
show
cellular
infiltr
polymorphonuclear
mononuclear
cell
immunofluoresc
microscopi
reveal
diffus
granular
deposit
igg
along
glomerular
basement
membran
gbm
mesangi
deposit
may
also
contain
igm
electron
microscopi
scatter
subepitheli
electrondens
deposit
seen
fusion
epitheli
cell
foot
process
good
evid
exist
renal
diseas
due
immunolog
mediat
reaction
treponem
antigen
antibodi
reactiv
treponem
antigen
elut
glomerular
deposit
treponem
antigen
present
immun
deposit
treatment
congenit
acquir
syphili
antibiot
result
rapid
improv
renal
manifest
renal
involv
surprisingli
rare
mycoplasma
pneumonia
infect
consid
preval
organ
propens
trigger
immunolog
mediat
diseas
erythema
multiform
arthriti
hemolysi
acut
nephriti
associ
mycoplasma
infect
may
occur
day
respiratori
tract
infect
case
iga
nephropathi
report
follow
mycoplasma
infect
renal
histopatholog
find
includ
type
mpgn
prolif
endocapillari
gn
minim
chang
diseas
antibiot
treatment
infect
appear
affect
renal
diseas
selflimit
case
sinc
recognit
legionnair
diseas
caus
legionella
pneumophila
emerg
import
caus
pneumonia
diseas
commonli
affect
elderli
report
normal
immunocompromis
children
renal
dysfunct
occur
minor
patient
develop
renal
failur
present
transient
azotemia
hematuria
proteinuria
pyuria
cylindruria
usual
sever
ill
bilater
pulmonari
infiltr
fever
leukocytosi
shock
may
present
renal
impair
associ
acut
rhabdomyolysi
high
level
creatin
phosphokinas
myoglobinuria
renal
histolog
examin
usual
show
tubulointerstiti
nephriti
acut
tubular
necrosi
pathogenesi
renal
impair
uncertain
organ
detect
within
kidney
electron
microscopi
immunofluoresc
studi
suggest
direct
toxic
effect
myoglobinuria
decreas
perfus
may
also
contribut
factor
howev
mortal
high
report
case
legionnair
diseas
complic
renal
failur
treatment
base
dialysi
intens
care
antimicrobi
therapi
erythromycin
steroid
therapi
may
effect
tubulointerstiti
nephriti
rickettsi
diseas
caus
famili
microorgan
characterist
common
bacteria
virus
caus
acut
febril
ill
associ
widespread
vascul
except
q
fever
associ
erythemat
rash
four
group
rickettsi
diseas
typhu
group
includ
louseborn
murin
typhu
spread
lice
flea
respect
mountain
spot
fever
tick
typhu
relat
mediterranean
spot
fever
rickettsi
pox
spread
tick
mite
rodent
natur
reservoir
scrub
typhu
spread
mite
q
fever
spread
inhal
infect
particl
infect
anim
rickettsi
diseas
worldwid
distribut
vari
wide
sever
selflimit
infect
fulmin
often
fatal
ill
view
widespread
vascul
associ
infect
subclin
renal
involv
probabl
occur
mani
rickettsi
diseas
howev
rocki
mountain
spot
fever
tick
typhu
q
fever
renal
involv
may
import
compon
ill
rocki
mountain
spot
fever
sever
rickettsi
diseas
incid
increas
last
decad
less
two
case
per
million
person
six
million
mortal
declin
time
period
children
year
compromis
immun
system
delay
diagnosi
increas
risk
fatal
prior
specif
antibiot
therapi
mortal
http
www
cdcgovrmsfstat
onset
occur
day
bite
infect
tick
major
case
occur
summer
month
high
fever
develop
initi
follow
pathognomon
rash
occur
second
sixth
day
ill
rash
initi
consist
small
erythemat
macul
later
becom
maculopapular
petechi
untreat
patient
confluent
hemorrhag
area
may
seen
rash
first
appear
peripheri
spread
trunk
involv
palm
sole
characterist
featur
headach
restless
mening
confus
may
occur
togeth
neurolog
sign
cardiac
involv
congest
heart
failur
arrhythmia
common
pulmonari
involv
occur
case
infect
associ
initi
leukopenia
follow
neutrophil
leukocytosi
thrombocytopenia
occur
case
histopatholog
predomin
lesion
vascular
system
rickettsia
multipli
endotheli
cell
result
focal
area
endotheli
cell
prolifer
perivascular
mononuclear
cell
infiltr
thrombosi
leakag
red
cell
tissu
renal
lesion
involv
blood
vessel
interstitium
acut
tubular
necrosi
may
occur
acut
gn
immunecomplex
deposit
report
case
patholog
appear
direct
consequ
invad
organ
renal
vasculatur
renal
dysfunct
import
complic
rocki
mountain
spot
fever
elev
urea
creatinin
level
occur
third
children
acidosi
common
aki
associ
increas
mortal
recent
mexican
cohort
factor
present
associ
increas
risk
develop
renal
impair
adult
increas
age
rise
bilirubin
thrombocytopenia
neurolog
involv
one
adult
case
seri
factor
associ
increas
mortal
rais
creatinin
rais
bilirubin
ast
hypernatremia
thrombocytopenia
increas
age
neurolog
involv
preren
renal
failur
caus
hypovolemia
impair
cardiac
function
may
respond
volum
replac
inotrop
support
aki
may
subsequ
occur
necessit
dialysi
rocki
mountain
spot
fever
diagnos
characterist
clinic
pictur
exclus
disord
similar
manifest
eg
measl
meningococc
diseas
leptospirosi
detect
specif
antibodi
convalesc
cultur
rickettsia
rickettsii
immunofluoresc
stain
polymeras
chain
reaction
pcr
test
blood
skin
biopsi
specimen
avail
refer
laboratori
antibiot
administ
suspect
case
without
await
confirm
diagnosi
doxycyclin
drug
choic
children
age
chloramphenicol
also
effect
intens
support
shock
multiorgan
failur
may
requir
sever
case
periton
dialysi
hemodialysi
may
requir
renal
function
return
q
fever
caus
coxiella
burnetii
worldwid
distribut
anim
reservoir
cattl
sheep
goat
human
infect
follow
inhal
infect
particl
environ
clinic
manifest
rang
acut
selflimit
febril
ill
atyp
pneumonia
involv
specif
organ
caus
endocard
hepat
osteomyel
central
nervou
system
diseas
prolif
gn
may
associ
either
q
fever
endocard
rhabdomyolysi
chronic
infect
elsewher
bodi
tubulointerstiti
nephriti
attribut
immunecomplex
deposit
usual
associ
chronic
rather
acut
diseas
incid
renal
complic
q
fever
unknown
due
small
number
case
report
recent
case
seri
patient
demonstr
renal
failur
renal
manifest
rang
asymptomat
proteinuria
hematuria
aki
hypertens
nephrot
syndrom
renal
histolog
find
diffus
prolif
gn
focal
segment
gn
mesangi
gn
immunofluoresc
studi
reveal
diffus
glomerular
deposit
igm
mesangi
togeth
fibrin
coxiella
burnetii
antigen
identifi
within
renal
lesion
igg
antibodi
cardiolipin
lupu
anticoagul
demonstr
acutephas
serum
sampl
treatment
underli
infect
may
result
remiss
renal
diseas
prolong
treatment
may
requir
endocard
doxycyclin
first
line
recommend
treatment
adult
children
link
dental
stain
occur
tetracyclin
use
children
age
hospit
q
fever
cotrimoxazol
use
safe
altern
deem
safe
pregnant
women
clarithromycin
acut
set
treatment
continu
day
fever
subsid
usual
durat
week
chronic
infect
requir
longer
treatment
usual
month
cdc
recommend
nephriti
report
associ
presenc
wide
rang
microorgan
caus
chronic
persist
infect
tabl
like
infecti
agent
releas
foreign
antigen
circul
includ
low
virul
caus
renal
injuri
either
deposit
foreign
antigen
kidney
format
immun
complex
circul
deposit
within
kidney
nephriti
commonli
seen
associ
intravascular
infect
sbe
infect
ventriculoatri
shunt
also
seen
focal
extravascular
infect
ear
nose
throat
infect
abscess
renal
involv
one
diagnost
featur
bacteri
endocard
virtual
organ
caus
endocard
also
produc
renal
involv
tabl
although
endocard
caus
bacteria
common
readili
diagnos
blood
cultur
unusu
import
caus
cultureneg
endocard
includ
q
fever
legionella
infect
immunocompromis
individu
opportunist
pathogen
fungi
mycobacteria
import
caus
usual
renal
manifest
sbe
asymptomat
proteinuria
hematuria
pyuria
loin
pain
hypertens
nephrot
syndrom
renal
failur
may
occur
sever
case
renal
lesion
occur
endocard
variabl
focal
embol
immunecomplexmedi
featur
may
coexist
embol
foci
may
evid
area
infarct
intracapillari
thrombosi
hemorrhag
commonli
focal
necrot
diffus
prolif
gn
immunofluoresc
studi
show
glomerular
deposit
igg
igm
iga
along
gbm
within
mesangium
electron
microscopi
reveal
typic
electrondens
deposit
along
gbm
within
mesangium
earli
report
suggest
renal
lesion
caus
microemboli
infect
veget
deposit
kidney
hypothesi
support
occasion
presenc
bacteria
within
renal
lesion
subsequ
evid
howev
indic
immunolog
mechan
rather
emboli
involv
pathogenesi
case
bacteria
rare
found
within
kidney
renal
involv
occur
lesion
right
side
heart
would
like
embol
kidney
immun
complex
contain
bacteri
antigen
present
circul
bacteri
antigen
bacteriaspecif
antibodi
demonstr
within
immun
deposit
kidney
serum
level
usual
low
complement
found
within
circul
deposit
immun
complex
featur
support
immunecomplexmedi
pathogenesi
renal
injuri
treatment
endocard
antibiot
usual
result
resolut
gn
associ
disappear
immun
complex
circul
return
level
normal
prognosi
renal
lesion
sbe
gener
depend
respons
underli
endocard
antibiot
case
antibiot
failur
surgic
remov
infect
veget
patient
previous
treat
shunt
hydrocephalu
welldocu
associ
gn
infect
ventriculoatri
shunt
incid
shunt
nephriti
decreas
due
prefer
ventriculoperiton
shunt
ventriculoatri
shunt
howev
shunt
nephriti
report
former
coagulaseneg
staphylococci
caus
organ
case
immunecomplex
diseas
chronic
hyperantigenemia
hyperglobulinemia
deposit
immunoglobulin
complement
immun
complex
glomerular
basement
membran
clinic
patholog
find
similar
sbe
present
featur
proteinuria
hematuria
pyuria
may
progress
renal
failur
immun
complex
contain
bacteri
antigen
complement
present
serum
depress
histolog
find
diffus
mesangiocapillari
gn
prognosi
renal
lesion
good
infect
treat
earli
usual
involv
remov
infect
shunt
replac
va
vp
shunt
administr
appropri
antibiot
though
possibl
progress
endstag
renal
diseas
requir
frequent
renal
monitor
patient
ventriculoatri
shunt
certain
case
report
also
seen
benefit
use
steroid
adjunct
therapi
focal
infect
gn
report
chronic
abscess
osteomyel
otiti
media
pneumonia
focal
infect
tabl
aki
present
featur
focal
infect
variou
site
includ
lung
pleura
abdomin
caviti
sinus
pelvi
mani
differ
organ
respons
includ
aureu
pseudomona
e
coli
proteu
speci
probabl
anoth
exampl
immunecomplex
gn
level
decreas
approxim
onethird
report
case
immunofluoresc
studi
reveal
diffus
granular
deposit
glomeruli
report
instanc
variabl
presenc
immunoglobulin
renal
lesion
mpgn
crescent
nephriti
renal
outcom
report
good
success
earli
treatment
underli
infect
role
viral
infect
causat
renal
diseas
less
well
defin
bacteri
infect
clearli
defin
associ
renal
diseas
made
hepat
b
viru
hbv
hepat
c
viru
hcv
hiv
hantavirus
role
virus
pathogenesi
renal
diseas
clearli
defin
virus
caus
system
infect
may
trigger
immunolog
mediat
renal
injuri
increas
applic
molecular
techniqu
may
signific
proport
gn
current
consid
idiopath
ultim
shown
viru
induc
children
immunodefici
state
undergo
renal
transplant
virus
cytomegaloviru
cmv
polyomaviru
recogn
associ
nephropathi
million
peopl
aliv
today
infect
hepat
b
point
live
million
becom
chronic
infect
carrier
diseas
estim
four
million
acut
case
per
year
per
year
carrier
one
million
die
cirrhosi
chronic
activ
hepat
primari
hepatocellular
carcinoma
infect
common
africa
orient
acquir
childhood
vertic
transmiss
infect
mother
horizont
transmiss
children
adult
develop
countri
transmiss
adult
occur
often
blood
product
exposur
sexual
contact
intraven
drug
use
epidemiolog
hbv
infect
children
chang
follow
widespread
use
effect
vaccin
birth
develop
develop
countri
hbv
complex
dna
viru
outer
surfac
envelop
hbsag
inner
nucleocapsid
core
contain
hepat
b
core
antigen
hbcag
dna
polymeras
protein
kinas
activ
viral
dna
incomplet
spheric
filament
viral
particl
consist
sole
hbsag
major
viral
product
circul
may
present
concentr
particl
per
millilit
serum
hepat
b
e
antigen
hbeag
releas
hbcag
proteolyt
treatment
may
found
circul
either
free
complex
albumin
igg
antibodi
presenc
hbeag
correl
presenc
complet
viral
particl
infect
individu
infect
hbv
may
result
either
selflimit
infecti
hepat
follow
clearanc
viru
complet
recoveri
chronic
persist
infect
immun
respons
ineffect
elimin
viru
chronic
hbv
infect
continu
presenc
viral
antigen
circul
caus
ineffect
host
immun
respons
provid
bestdocu
exampl
immunolog
mediat
renal
injuri
caus
persist
infect
risk
chronic
infect
vari
invers
age
infant
infect
birth
develop
chronic
infect
compar
children
infect
year
peopl
infect
older
children
adult
chronic
infect
also
common
immunodefici
immunolog
mediat
renal
diseas
sever
form
renal
diseas
secondari
hepat
b
infect
identifi
includ
membran
glomerulonephr
mesangioprolif
glomerulonephr
well
iga
nephropathi
focal
segment
glomerulosclerosi
fsg
hepat
b
also
link
polyarter
nodosa
pan
prodrom
ill
earli
prodrom
phase
hbv
hepat
onset
jaundic
patient
develop
fever
maculopapular
urticari
rash
transient
arthralgia
arthriti
occasion
proteinuria
hematuria
steril
pyuria
observ
syndrom
usual
last
day
often
resolv
onset
jaundic
histolog
studi
renal
chang
prodrom
period
hepat
b
virusassoci
polyarter
nodosa
hbv
infect
associ
polyarter
nodosa
vascul
affect
smalland
mediums
vessel
hbv
pan
case
adult
disord
also
report
children
estim
approxim
onethird
pan
case
caus
hbv
hbv
pan
appear
uncommon
africa
orient
infect
usual
acquir
childhood
declin
incid
follow
introduct
hbv
vaccin
hbv
pan
present
week
month
clinic
mild
hepat
may
occasion
predat
hepat
prodrom
ill
frank
vascul
affect
virtual
organ
appear
abdomin
pain
fever
mononeur
multiplex
pulmonari
renal
involv
may
occur
first
clinic
present
hepat
b
renal
involv
may
appear
hypertens
hematuria
proteinuria
renal
failur
laboratori
investig
reveal
florid
acutephas
respons
leukocytosi
anemia
transaminas
level
usual
elev
hbsag
present
circul
patholog
consist
focal
inflamm
smalland
mediums
arteri
fibrinoid
necrosi
leukocyt
infiltr
fibrin
deposit
renal
patholog
may
limit
mediums
arteri
may
coexist
gn
circul
immun
complex
contain
hbsag
antihb
antibodi
usual
present
circul
total
hemolyt
complement
level
depress
posit
anca
exclud
hbv
pan
although
evid
suggest
pathogenesi
involv
immunecomplexmedi
vascul
autoantibodyor
cellmedi
vascular
injuri
may
coexist
condit
untreat
mortal
high
studi
suggest
steroid
immunosuppress
help
suppress
vascul
potenti
predispos
chronic
infect
progress
liver
diseas
success
treatment
hepat
bassoci
pan
nucleosid
analogu
lamivudin
newer
antivir
drug
either
alon
combin
interferonalpha
convent
immunosuppress
therapi
report
hepat
b
virusassoci
membran
glomerulonephr
hbv
major
caus
membran
gn
mgn
children
worldwid
proport
patient
mgn
caus
hbv
directli
relat
incid
hbsag
popul
case
mgn
african
orient
countri
associ
hbv
see
chap
membran
nephropathi
children
hbv
mgn
usual
present
children
age
strike
male
predomin
viru
usual
acquir
vertic
transmiss
infect
mother
horizont
infect
famili
member
unlik
adult
hbv
mgn
children
usual
histori
hepat
activ
liver
diseas
liver
function
test
result
gener
mildli
abnorm
liver
biopsi
specimen
may
show
minim
abnorm
chronic
persist
hepat
occasion
sever
chang
renal
manifest
usual
proteinuria
nephrot
syndrom
microscop
hematuria
rare
macroscop
hematuria
hypertens
occur
less
case
renal
insuffici
rare
hbsag
hbcag
usual
present
circul
hbe
antigenemia
seen
high
proport
case
occasion
hbsag
may
found
glomeruli
absent
circul
level
often
low
circul
immun
complex
found
case
immunohistolog
studi
reveal
deposit
igg
less
commonli
igm
iga
subepitheli
subendotheli
mesangi
tissu
hbv
particl
may
seen
electron
microscopi
major
hepat
b
antigen
includ
hbsag
hbcag
hbeag
local
glomerular
capillari
wall
immunofluoresc
immunolog
deposit
hbv
antibodi
glomerular
capillari
wall
clearli
involv
glomerular
injuri
underli
immunolog
event
incomplet
understood
passiv
trap
circul
immun
complex
may
involv
circul
immun
complex
contain
hbsag
usual
larger
would
expect
penetr
basement
membran
hbsag
hbcag
anion
therefor
unlik
penetr
glomerular
capillari
wall
contrast
hbeag
form
smaller
complex
antihb
antibodi
may
readili
penetr
gbm
may
explain
observ
hbeag
circul
frequent
correl
sever
diseas
altern
mechan
immunemedi
glomerular
injuri
trap
hbv
antigen
antibodi
previous
deposit
kidney
antihb
antibodi
cation
may
readili
local
glomerulu
subsequ
bind
circul
antigen
complement
third
possibl
deposit
hbv
antibodi
consequ
glomerular
injuri
cellular
mechan
autoantibodi
littl
evid
support
view
present
transgen
mous
model
hbvassoci
nephropathi
develop
hbsag
hbcag
express
liver
kidney
particularli
tubular
epitheli
cell
without
viral
replic
mice
gene
express
analysi
reveal
upregul
acutephas
protein
particularli
although
measur
serum
level
reduc
support
notion
local
persist
express
hbv
viral
protein
contribut
hbvassoci
nephropathi
hepat
b
viru
glomerulonephritid
hbv
infect
associ
varieti
form
gn
adult
children
mpgn
mesangi
prolif
gn
may
trigger
hbv
sever
countri
hbv
common
proport
patient
form
nephritid
test
posit
hbv
greatli
exce
incid
posit
gener
popul
mgn
hbvassoci
pan
circul
immun
complex
local
hbv
antigen
glomeruli
report
mpgn
mesangi
prolif
gn
like
similar
mechan
occur
sever
form
gn
associ
hbv
includ
iga
nephropathi
focal
glomerulosclerosi
crescent
nephriti
system
lupu
erythematosu
evid
associ
less
consist
entiti
discuss
earlier
glomerulonephr
hbv
normal
clear
result
cellmedi
respons
cytotox
cell
natur
killer
cell
elimin
infect
hepatocyt
surpris
therefor
administr
steroid
immunosuppress
agent
either
may
effect
hbv
diseas
may
increas
risk
progress
diseas
children
hbv
mgn
good
prognosi
twothird
undergo
spontan
remiss
within
year
diagnosi
steroid
therapi
appear
provid
addit
benefit
antivir
therapi
pegyl
interferonalpha
lamivudin
use
treat
hbv
case
elimin
infect
antivir
therapi
children
adult
associ
improv
resolut
coexist
renal
diseas
isol
case
report
pegyl
interferon
success
treat
iga
nephropathi
associ
hbv
promis
result
newer
antivir
agent
adefovir
entecavir
treat
hbv
glomerulonephr
combin
regimen
hcv
envelop
singlestrand
rna
viru
approxim
kilobas
flavivirida
famili
six
major
hcv
genotyp
hepat
c
common
diseas
affect
approxim
million
peopl
worldwid
unit
state
million
person
estim
antihcv
posit
million
may
chronic
infect
estim
children
unit
state
antibodi
hcv
chronic
infect
children
becom
infect
receipt
contamin
blood
product
vertic
transmiss
risk
vertic
transmiss
increas
higher
matern
viremia
matern
coinfect
hiv
acut
hcv
infect
rare
recogn
children
outsid
special
circumst
known
exposur
hcvinfect
mother
blood
transfus
chronic
infect
children
asymptomat
normal
mildli
abnorm
alanin
aminotransferas
level
although
natur
histori
hcv
infect
childhood
seem
benign
major
instanc
infect
take
aggress
cours
proport
children
lead
cirrhosi
endstag
liver
diseas
childhood
factor
respons
aggress
cours
unidentifi
even
adult
natur
histori
hcv
infect
variabl
cours
signific
proport
patient
develop
degre
liver
dysfunct
eventu
endstag
liver
diseas
result
cirrhosi
risk
hepatocellular
carcinoma
signific
establish
cirrhosi
hepat
c
current
common
condit
lead
liver
transplant
adult
western
world
gn
describ
import
complic
chronic
infect
hcv
adult
clinic
present
usual
nephrot
syndrom
proteinuria
hypertens
hematuria
without
azotemia
mpgn
without
cryoglobulinemia
mgn
commonli
describ
isol
case
report
unusu
pattern
glomerular
injuri
includ
iga
nephropathi
focal
segment
glomerulosclerosi
crescent
gn
fibrillari
gn
thrombot
microangiopathi
also
associ
hcv
infect
glomerular
deposit
hepat
antigen
antibodi
describ
believ
play
role
pathogenesi
cryoglobulinemia
common
accompani
gn
associ
depress
serum
complement
level
renal
failur
may
develop
patient
mpgn
presenc
viruslik
particl
well
viral
rna
within
kidney
section
patient
hcvassoci
glomerulopathi
report
diagnosi
suspect
glomerular
diseas
associ
chronic
hepat
particularli
presenc
cryoglobulin
renal
biopsi
necessari
establish
definit
diagnosi
hcv
infect
rel
common
children
endstag
renal
diseas
import
caus
liver
diseas
popul
hcvinfect
renal
transplant
recipi
higher
mortal
hospit
rate
transplant
recipi
hcv
infect
report
associ
de
novo
immunemedi
gn
especi
type
mpgn
renal
allograft
result
acceler
loss
graft
function
pedsc
trial
random
control
trial
children
adolesc
shown
ribavirin
pegyl
interferon
superior
pegyl
interferon
placebo
treat
chronic
hepat
c
age
group
combin
constitut
us
standard
care
clinic
trial
current
underway
investig
efficaci
new
gener
hcv
antivir
drug
includ
sofosbuvir
boceprevir
telaprevir
combin
pegyl
interferon
ribavirin
tripl
therapi
associ
higher
sustain
virolog
respons
adult
treatment
ribavirin
mostli
associ
improv
vasculit
symptom
case
exacerb
rare
new
onset
vascul
peripher
nervou
system
describ
treatment
fulmin
case
immunosuppress
therapi
steroid
cyclophosphamid
rituximab
may
need
control
lifethreaten
vascul
prior
antivir
treatment
cmv
one
eight
human
herp
virus
transmiss
viru
requir
exposur
infect
bodi
fluid
breast
milk
saliva
urin
blood
individu
initi
infect
cmv
may
asymptomat
display
nonspecif
flulik
symptom
initi
infect
cmv
like
herp
virus
establish
latenc
life
period
excret
asymptomat
host
cmv
replic
within
renal
cell
biopsi
sampl
immunocompromis
host
viral
inclus
visual
light
microscopi
cell
convolut
tubul
collect
duct
glomerular
cell
shed
renal
tubular
cell
may
characterist
inclus
clinic
evid
renal
diseas
rare
seen
virtual
immunocompromis
congenit
infect
children
clinic
manifest
cmvinduc
renal
diseas
congenit
infect
infant
variabl
rang
asymptomat
proteinuria
nephrot
syndrom
renal
impair
congenit
cmv
infect
histolog
chang
viral
inclus
commonli
occur
tubul
addit
prolif
gn
report
evid
electron
microscopi
viral
immun
deposit
glomerular
cell
cmvinfect
immunocompromis
patient
immunecomplex
gn
document
mesangi
deposit
igg
iga
cmv
antigen
within
glomeruli
elut
glomerular
immunoglobulin
shown
contain
cmv
antigen
cmv
common
viral
infect
kidney
transplant
experi
pediatr
kidney
transplant
recipi
suggest
incid
cmv
infect
approxim
neg
time
transplant
direct
indirect
effect
cmv
infect
result
signific
morbid
mortal
among
kidney
transplant
recipi
cmvneg
patient
receiv
cmvposit
allograft
risk
primari
infect
graft
dysfunct
patient
cmv
seroposit
time
transplant
also
risk
reactiv
superinfect
tubulointerstiti
nephriti
wellcharacter
patholog
featur
renal
allograft
cmv
diseas
difficult
distinguish
injuri
caus
reject
histolog
evid
endotheli
cell
injuri
mononuclear
cell
infiltr
glomeruli
report
cmv
glomerular
vasculopathi
absenc
tubulointerstiti
diseas
caus
renal
allograft
dysfunct
also
report
beyond
acut
allograft
nephropathi
associ
cmv
viremia
cmv
known
caus
chronic
vascular
injuri
may
advers
affect
longterm
outcom
allograft
may
explan
observ
associ
chronic
allograft
nephropathi
techniqu
rapidli
diagnos
cmv
infect
includ
shell
vial
cultur
antigenemia
assay
pcr
hybridcaptur
rnadna
hybrid
assay
qualit
detect
cmv
pcr
revers
transcriptas
pcr
rt
pcr
detect
viral
mrna
transcript
peripher
blood
less
sensit
pcr
immun
histocytochemistri
use
diagnos
endorgan
diseas
quantit
plasma
pcr
test
pcr
viral
load
increasingli
use
diagnosi
monitor
cmv
viremia
renal
transplant
recipi
american
societi
transplant
ast
recommend
monitor
cmv
quantit
viral
load
monthli
first
year
transplant
kidney
diseas
improv
global
outcom
kdigo
recommend
addit
monthli
surveil
second
year
antivir
agent
shown
effect
cmv
includ
ganciclovir
valganciclovir
foscarnet
cidofovir
ganciclovir
remain
drug
choic
treat
establish
diseas
intraven
ganciclovir
therapi
prefer
children
errat
absorpt
oral
ganciclovir
major
limit
ganciclovir
therapi
induct
renal
tubular
dysfunct
bone
marrow
toxic
princip
neutropenia
thrombocytopenia
dosag
adjust
necessari
recipi
renal
dysfunct
oral
valganciclovir
recommend
cmv
prophylaxi
posttranspl
durat
chemoprophylaxi
depend
serostatu
donor
recipi
effect
reduc
incid
symptomat
cmv
prospect
viral
surveil
studi
shown
subclin
infect
pediatr
kidney
transplant
recipi
henc
import
viral
surveil
use
antivir
agent
foscarnet
cidofovir
limit
nephrotox
difficulti
administr
role
hightit
cmv
immunoglobulin
therapi
reduc
sever
cmvassoci
diseas
stem
cell
transplant
remain
unclear
associ
varicella
nephriti
known
year
sinc
henoch
report
four
children
nephriti
occur
appear
varicella
vesicl
varicella
howev
rare
associ
renal
complic
fatal
case
dissemin
varicella
immunocompromis
individu
renal
involv
common
histolog
find
fatal
case
includ
congest
hemorrhag
glomeruli
endotheli
cell
hyperplasia
tubular
necrosi
mild
nonfat
case
nonimmunocompromis
individu
varicella
occasion
associ
varieti
renal
manifest
rang
mild
nephriti
nephrot
syndrom
aki
histolog
find
includ
endocapillari
cell
prolifer
epitheli
endotheli
cell
hyperplasia
inflammatori
cell
infiltr
rapidli
progress
nephriti
also
report
immunohistochem
studi
reveal
glomerular
deposit
igg
igm
iga
electron
microscopi
granular
electrondens
deposit
found
paramesangi
region
varicella
antigen
may
deposit
glomeruli
featur
suggest
immunecomplex
nephriti
elev
circul
level
igg
iga
immun
complex
depress
level
support
possibl
fulmin
dissemin
varicella
varicella
immunocompromis
patient
treat
intraven
acyclovir
renal
involv
common
acut
infecti
mononucleosi
usual
manifest
abnorm
urin
sediment
hematuria
case
hematuria
either
microscop
macroscop
usual
appear
within
first
week
ill
last
week
month
proteinuria
usual
absent
low
grade
sever
renal
involv
proteinuria
nephrot
syndrom
acut
nephriti
renal
failur
much
less
common
aki
may
seen
cours
fulmin
infecti
mononucleosi
associ
hepat
failur
thrombocytopenia
enceph
usual
caus
interstiti
nephriti
like
result
immunopatholog
injuri
precipit
epsteinbarr
viru
ebv
infect
howev
identif
ebv
dna
kidney
rais
possibl
direct
infect
might
play
role
renal
involv
must
distinguish
myoglobinuria
caus
rhabdomyolysi
may
occur
infecti
mononucleosi
bleed
renal
tract
result
thrombocytopenia
renal
histolog
find
ebv
nephriti
interstiti
nephriti
mononuclear
cell
infiltr
foci
tubular
necrosi
glomeruli
may
show
vari
degre
mesangi
prolifer
immunohistochem
studi
ebv
antigen
seen
glomerular
tubular
deposit
prognosi
complet
recoveri
renal
function
good
treatment
corticosteroid
may
role
manag
ebvinduc
aki
may
shorten
durat
renal
failur
ebvassoci
posttransplant
lymphoprolif
diseas
recogn
complic
renal
transplant
recipi
subclin
infect
occur
pediatr
renal
transplant
recipi
latent
infect
ebv
renal
proxim
tubular
epitheli
cell
describ
caus
idiopath
chronic
tubulointerstiti
nephriti
herp
simplex
viru
hsv
caus
persist
infect
character
asymptomat
latent
period
interspers
acut
relaps
chronic
persist
infect
immunolog
mediat
disord
trigger
hsv
well
recogn
perhap
surpris
hsv
rare
link
nephriti
acut
nephriti
nephrot
syndrom
associ
herp
simplex
enceph
renal
histolog
show
focal
segment
gn
mesangi
segment
deposit
igm
hsv
antigen
herp
virus
hsv
suggest
trigger
iga
nephriti
mpgn
membran
nephropathi
conclus
evid
exist
etiolog
role
hsv
renal
involv
occur
hivinfect
children
unit
state
sinc
develop
antiretrovir
therapi
art
howev
incid
endstag
renal
diseas
hiv
infect
adult
children
industri
countri
declin
predict
dramat
declin
aidsrel
death
lead
age
popul
hivinfect
individu
risk
nonhivrel
renal
problem
number
hivposit
esrd
patient
increas
unit
state
hiv
infect
associ
number
renal
patholog
hivassoci
nephropathi
hivan
syndrom
glomerular
tubular
dysfunct
progress
endstag
renal
failur
discuss
fulli
glomerular
syndrom
hivan
includ
rang
immunemedi
syndrom
hiv
immunecomplex
kidney
diseas
hivick
includ
mgn
resembl
lupu
nephriti
immunecomplex
gn
iga
nephropathi
hcvassoci
mpgn
common
form
also
sever
case
report
amyloid
kidney
kidney
may
affect
variou
mechan
opportunist
infect
organ
bk
viru
bkv
give
rise
nephropathi
hemorrhag
cystiti
report
associ
hiv
infect
system
infect
accompani
hypotens
caus
preren
failur
lead
acut
tubular
necrosi
acut
tubular
necrosi
also
report
hiv
patient
use
nephrotox
drug
pentamidin
foscarnet
cidofovir
amphotericin
b
aminoglycosid
intratubular
obstruct
crystal
precipit
occur
use
sulfonamid
intraven
acyclovir
indinavir
well
recogn
caus
nephropathi
renal
calculi
mpgn
associ
mix
cryoglobulinemia
thrombot
microangiopathyatyp
hu
associ
hiv
infect
report
hivan
character
glomerular
tubular
dysfunct
pathogenesi
entir
known
hivan
clinicopatholog
entiti
includ
proteinuria
azotemia
focal
segment
glomerulosclerosi
mesangi
hyperplasia
tubulointerstiti
diseas
adult
unit
state
markedli
increas
risk
nephropathi
among
african
american
person
hiv
infect
appear
true
children
well
data
spars
spectrum
hivan
seem
coincid
degre
aid
symptomatolog
thought
hivan
present
point
hiv
infect
patient
hivan
count
less
cellsml
suggest
may
primarili
manifest
latestag
diseas
microscop
featur
hivan
children
compris
classic
fsg
without
mesangi
hyperplasia
combin
microcyst
tubular
dilat
interstiti
inflamm
collaps
fsg
hallmark
adult
diseas
shown
children
well
affect
glomeruli
viscer
epitheli
cell
hypertrophi
hyperplast
contain
larg
cytoplasm
vacuol
numer
protein
resorpt
droplet
microcyst
distort
tubul
segment
contribut
increas
kidney
size
podocyt
hyperplasia
becom
mark
caus
obliter
much
urinari
space
form
pseudocresc
capillari
wall
wrinkl
collaps
obliter
capillari
lumina
interstitium
edemat
variabl
degre
tcell
infiltr
bowman
capsul
also
dilat
fill
precipit
plasma
protein
repres
glomerular
ultrafiltr
one
distinct
featur
hivan
howev
presenc
numer
tubuloreticular
inclus
within
cytoplasm
glomerular
peritubular
capillari
endotheli
cell
immunofluoresc
test
posit
igm
capillari
wall
coars
granular
amorph
pattern
segment
distribut
presenc
hiv
genom
glomerular
tubular
epithelium
demonstr
use
complementari
dna
probe
situ
hybrid
provir
dna
detect
pcr
glomeruli
tubul
interstitium
microdissect
kidney
patient
patholog
evid
hivan
also
detect
kidney
hivposit
patient
glomerulopathi
undetect
level
viral
rna
peripher
blood
kidney
postul
behav
separ
compart
blood
ongo
viral
replic
kidney
despit
achiev
serolog
suppress
art
transgen
murin
model
provid
strongest
evid
direct
role
induct
hivan
mice
produc
infecti
viru
express
hiv
envelop
regulatori
gene
level
suffici
recreat
hivan
seen
human
anim
model
shown
nef
vpr
gene
contribut
hivan
encod
podocyt
dysfunct
apoptosi
renal
tubular
epitheli
cell
respect
hiv
thought
infect
renal
tubuloepitheli
cell
direct
cellcel
transmiss
act
separ
viral
compart
facilit
replic
distant
blood
hivan
host
suscept
gene
identifi
anim
model
hivan
two
variant
gene
identifi
suscept
allel
contribut
increas
risk
fsg
african
american
previous
attribut
chromosom
hivan
like
patient
famili
histori
esrd
hivan
manifest
mild
proteinuria
nephrot
syndrom
renal
tubular
acidosi
hematuria
andor
aki
nephrot
syndrom
chronic
renal
insuffici
late
manifest
hivan
children
hivan
like
develop
transient
electrolyt
disord
heavi
proteinuria
aki
due
system
infecti
episod
nephrotox
drug
earli
stage
hivan
identifi
presenc
proteinuria
urin
microcyst
along
renal
sonogram
show
enlarg
echogen
kidney
urinari
renal
tubular
epitheli
cell
frequent
group
togeth
form
microcyst
found
urin
children
hivan
renal
tubular
injuri
advanc
stage
hivan
typic
present
nephrot
syndrom
edema
heavi
proteinuria
hypoalbuminemia
red
white
blood
cell
urinari
sediment
hypertens
may
present
usual
blood
pressur
within
normal
rang
hivan
adult
follow
rapidli
progress
cours
endstag
renal
diseas
develop
within
month
children
rapid
progress
necessarili
occur
definit
diagnosi
hivan
base
biopsi
result
biopsi
perform
signific
proteinuria
present
approxim
hivinfect
patient
azotemia
andor
proteinuria
h
undergo
renal
biopsi
specimen
histolog
featur
consist
renal
diseas
hivck
thought
aris
deposit
immun
complex
situ
format
immun
complex
parenchyma
immun
complex
consist
hiv
antigen
bound
igg
iga
iga
nephropathi
membran
membranoprolif
glomerulonephr
lupuslik
glomerulonephr
includ
hivck
like
hivan
occur
afrocaribbean
also
found
caucasian
acut
interstiti
nephriti
result
mainli
medic
use
treat
hiv
complic
nonsteroid
antiinflammatori
drug
rifampicin
cotrimoxazol
proteas
inhibitor
pi
like
idinavir
ritonavir
implic
class
art
caus
renal
toxic
except
integras
inhibitor
antagonist
tenofovir
caus
proxim
tubular
nephropathi
present
complet
partial
fanconi
syndrom
therefor
essenti
children
art
regular
urinalysi
check
emerg
proteinuria
hematuria
haart
given
children
symptomat
hiv
diseas
specif
treatment
hivan
remain
controversi
sever
studi
look
role
haart
without
angiotensin
iconvert
enzym
ace
inhibitor
even
cyclosporin
somewhat
encourag
result
howev
yet
random
casecontrol
trial
undertaken
studi
small
retrospect
mani
includ
patient
without
renal
biopsyproven
hivan
cyclosporin
use
treat
hivan
children
remiss
nephrot
syndrom
similar
respons
report
treatment
corticosteroid
variou
studi
howev
steroid
current
recommend
routin
manag
hivan
shortterm
improv
kidney
function
children
lymphoid
interstiti
pneumon
risk
exacerb
infect
tb
use
develop
countri
absenc
haart
shown
limit
progress
hivan
children
gener
regimen
use
treat
patient
hiv
includ
haart
appli
children
hivan
dosag
medic
must
adjust
patient
glomerular
filtrat
report
spontan
regress
hivan
support
manag
treatment
haart
particularli
regimen
contain
proteas
inhibitor
kidney
transgen
mice
found
elev
level
messeng
rna
protein
furthermor
gene
express
analysi
tubular
epitheli
cell
patient
hivan
found
upregul
sever
inflammatori
mediat
gene
downstream
interleukin
transcript
factor
nfkb
sever
therapeut
option
aim
specif
presum
role
pathogenesi
hivan
treatment
direct
synthesi
use
gene
therapi
block
gene
express
explor
therapi
direct
decreas
activ
use
antibodi
inhibitori
substanc
also
area
investig
date
novel
therapeut
approach
yield
promis
advanc
treatment
haart
era
outlook
hiv
patient
esrd
improv
patient
fare
wors
esrd
patient
without
hiv
report
hivinfect
patient
hemodialysi
shown
poor
prognosi
mean
patient
surviv
time
rang
month
mortal
therefor
still
close
within
first
year
dialysi
gener
improv
surviv
associ
younger
age
initi
hemodialysi
higher
count
complic
infect
thrombosi
tend
occur
higher
rate
hivinfect
hemodialysi
patient
cross
infect
hiv
dialysi
patient
rare
periton
dialysi
altern
hivinfect
patient
incid
periton
vari
across
studi
studi
report
higher
incid
pseudomona
fungal
periton
hivposit
popul
infect
unusu
organ
pasteurella
multocida
trichosporon
beigelii
mycobacterium
aviumintracellular
complex
also
report
sever
studi
howev
suggest
signific
differ
hivinfect
nonhivinfect
popul
note
viru
capabl
replic
vitro
recov
periton
dialysi
effluent
recover
day
dialysi
bag
room
temperatur
h
dri
exchang
tube
kidney
transplant
hivinfect
individu
endstag
renal
diseas
shown
excel
surviv
rate
group
patient
experi
increas
risk
reject
opportunist
infect
issu
revolv
around
immunosuppress
therapi
interact
art
human
polyomavirus
member
papovaviru
famili
signific
pathogen
immunocompromis
patient
nonenvelop
virus
rang
size
nm
circular
doublestrand
dna
genom
replic
host
nucleu
bestknown
speci
genu
bkv
jc
viru
jcv
simian
viru
bkv
establish
infect
kidney
urinari
tract
activ
caus
number
disord
includ
nephropathi
hemorrhag
cystiti
bkvassoci
nephropathi
caus
renal
dysfunct
renal
transplant
patient
jcv
establish
latenc
mainli
kidney
reactiv
result
develop
progress
multifoc
leukoencephalopathi
report
nephropathi
associ
jcv
infect
bkv
pose
much
bigger
problem
regard
bkv
infect
endem
worldwid
seropreval
rate
high
report
among
adult
unit
state
europ
peak
incid
primari
infect
measur
acquisit
antibodi
occur
children
year
age
bkv
antibodi
may
detect
mani
children
year
age
children
year
age
antibodi
wane
thereaft
bkv
infect
may
particularli
import
pediatr
transplant
popul
primari
infect
high
probabl
occur
children
immunosuppress
primari
infect
bkv
healthi
children
rare
associ
clinic
manifest
mild
pyrexia
malais
vomit
respiratori
ill
pericard
transient
hepat
dysfunct
report
primari
infect
investig
hypothes
initi
round
viral
replic
site
entri
viremia
follow
dissemin
viru
distant
site
latent
infect
establish
frequent
recogn
secondari
site
latent
infect
renal
uroepitheli
cell
reactiv
urinari
shed
occur
immunocompet
individu
higher
rate
among
immunocompromis
secondari
infect
report
caus
tubulointerstiti
nephriti
ureter
stenosi
renal
transplant
patient
may
renal
impair
immunocompromis
patient
nonren
solid
organ
transplant
recipi
found
frequent
associ
bkv
infect
report
preval
bkv
nephropathi
renal
allograft
asymptomat
infect
character
viral
shed
without
appar
clinic
featur
viruria
result
either
primari
secondari
infect
persist
sever
week
year
tubulointerstiti
nephriti
associ
bkv
renal
transplant
recipi
accompani
histopatholog
chang
without
function
impair
infect
diseas
must
differenti
care
bkv
infect
either
primari
reactiv
progress
bkv
diseas
alway
furthermor
case
bkv
diseas
lead
renal
impair
howev
infect
progress
transplant
dysfunct
graft
loss
although
diagnosi
may
complic
coexist
activ
allograft
reject
bkv
nephriti
bimod
distribut
bkvrelat
interstiti
nephriti
case
occur
week
transplant
remaind
patient
develop
diseas
month
year
transplant
allograft
failur
due
mainli
extens
viral
replic
tubular
epitheli
cell
lead
frank
tubular
necrosi
although
damag
potenti
fulli
revers
earli
diseas
persist
viral
damag
lead
irrevers
interstiti
fibrosi
tubular
atrophi
allograft
loss
observ
affect
patient
case
bkv
nephropathi
adult
renal
transplant
recipi
repres
secondari
infect
associ
reject
treatment
children
howev
primari
bkv
infect
give
rise
allograft
dysfunct
may
occur
definit
diagnosi
bkv
nephropathi
requir
renal
biopsi
histopatholog
featur
includ
sever
tubular
injuri
cellular
enlarg
mark
nuclear
atypia
epitheli
necrosi
denud
tubular
basement
membran
focal
intratubular
neutrophil
infiltr
mononuclear
interstiti
infiltr
without
concurr
tubulin
constel
histolog
featur
particularli
sever
tubul
often
misinterpret
reject
even
experienc
pathologist
presenc
welldemarc
basophil
amphophil
intranuclear
viral
inclus
primarili
within
tubular
pariet
epithelium
bowman
capsul
help
distinguish
bkv
diseas
reject
addit
test
immunohistochemistri
pcr
analysi
electron
microscopi
biopsi
tissu
aim
identif
bkv
may
requir
pcr
assay
viral
load
tubular
cell
report
sensit
marker
diagnosi
monitor
implic
bk
viru
renal
transplant
bkv
infect
may
caus
ureter
obstruct
due
ureter
ulcer
stenosi
ureter
anastomosi
bkvassoci
ureter
stenosi
report
renal
transplant
patient
usual
occur
day
transplant
ulcer
due
inflamm
prolifer
transit
epitheli
cell
smooth
muscl
prolifer
may
lead
partial
total
obstruct
highlevel
bkv
replic
implic
acut
lateonset
longdur
hemorrhag
cystiti
bone
marrow
transplant
two
case
report
children
renal
carcinoma
aris
transplant
kidney
associ
bk
viru
nephropathi
remain
unclear
whether
bk
viru
oncogen
potenti
transplant
set
possibl
given
big
antigen
tag
express
polyomaviru
famili
virus
shown
abil
disrupt
chromosom
integr
whether
patient
asymptomat
viremia
viruria
need
specif
therapeut
intervent
certain
review
literatur
suggest
care
reduct
immun
suppress
combin
activ
surveil
reject
result
clinic
improv
reduct
immunosuppress
may
precipit
episod
acut
cellular
reject
need
judici
treat
corticosteroid
outcom
bkv
nephropathi
unpredict
stabil
renal
function
may
occur
regardless
whether
mainten
immunotherapi
alter
cyclosporin
mycophenol
sirolimu
shown
possess
vitro
antivir
activ
bk
viru
find
confirm
vivo
clinic
trial
sever
studi
sought
identifi
particular
immunosuppress
combin
drug
increas
risk
bk
viru
result
favor
one
particular
regimen
anoth
systemat
review
johnston
et
al
adult
found
reduct
graft
loss
combin
cidofovir
leflunomid
immunosuppress
reduct
treat
polyomavirusassoci
nephropathi
prospect
trial
requir
address
impact
variou
immunosuppress
agent
bk
viru
replic
random
control
trial
still
requir
defin
optim
treatment
condit
viral
hemorrhag
fever
involv
least
distinct
rna
virus
share
propens
caus
sever
diseas
promin
hemorrhag
manifest
viral
hemorrhag
fever
wide
distribut
throughout
temper
tropic
region
world
import
caus
mortal
morbid
mani
countri
viral
hemorrhag
fever
zoonos
possibl
except
dengu
viru
viru
endem
anim
human
infect
acquir
bite
insect
vector
aerosol
nosocomi
transmiss
infect
patient
import
lassa
junin
machupo
congocrimean
hemorrhag
fever
marburg
ebola
virus
viral
hemorrhag
fever
mani
clinic
similar
also
import
differ
sever
major
organ
affect
prognosi
respons
treatment
viral
hemorrhag
fever
sever
case
occur
minor
affect
subclin
infect
nonspecif
febril
ill
occur
major
fever
myalgia
headach
conjunctiv
suffus
erythemat
rash
occur
viral
hemorrhag
fever
hemorrhag
manifest
rang
petechia
bleed
venipunctur
site
sever
hemorrhag
gi
tract
kidney
organ
capillari
leak
syndrom
evid
hemoconcentr
pulmonari
edema
oliguria
ultim
shock
occur
sever
affect
patient
renal
involv
occur
viral
hemorrhag
fever
proteinuria
common
preren
failur
seen
sever
case
complic
shock
howev
congocrimean
hemorrhag
fever
hemorrhag
fever
renal
syndrom
hfr
interstiti
nephriti
may
hemorrhag
characterist
renal
impair
major
compon
ill
dengu
caus
flaviviru
endem
epidem
tropic
america
africa
asia
mosquito
vector
aed
aegypti
present
classic
dengu
selflimit
nonfat
diseas
dengu
hemorrhag
fever
dengu
shock
syndrom
occur
minor
patient
high
mortal
aggress
treat
fluid
incub
period
day
ill
begin
fever
headach
arthralgia
weak
vomit
hyperesthesia
uncompl
dengu
fever
usual
last
day
shortli
onset
maculopapular
rash
appear
spare
palm
sole
occasion
follow
desquam
fever
may
reappear
onset
rash
dengu
hemorrhag
fever
dengu
shock
syndrom
typic
febril
ill
complic
hemorrhag
manifest
rang
posit
tourniquet
test
result
petechia
purpura
epistaxi
gi
bleed
thrombocytopenia
evid
consumpt
coagulopathi
increas
capillari
permeabl
suggest
hemoconcentr
edema
pleural
effus
sever
case
hypotens
shock
superven
larg
result
hypovolemia
renal
manifest
includ
oliguria
proteinuria
hematuria
rise
urea
creatinin
aki
occur
patient
sever
shock
primarili
result
renal
underperfus
howev
glomerular
inflammatori
chang
may
also
occur
children
dengu
hemorrhag
fever
show
hypertrophi
endotheli
mesangi
cell
mononuclear
cell
infiltr
thin
basement
membran
deposit
igg
igm
electron
microscopi
show
viral
particl
within
glomerular
mononuclear
cell
diagnosi
dengu
made
isol
viru
blood
serolog
test
specif
antivir
treatment
manag
patient
dengu
shock
syndrom
dengu
hemorrhag
fever
depend
aggress
circulatori
support
volum
replac
colloid
crystalloid
correct
hypovolemia
renal
impair
usual
revers
dialysi
may
requir
patient
establish
aki
yellow
fever
caus
flaviviru
transmit
mosquito
bite
typic
aed
speci
remain
import
public
health
problem
africa
south
america
renal
manifest
common
includ
albuminuria
oliguria
next
day
first
manifest
infect
shock
delirium
coma
renal
failur
develop
death
occur
day
onset
symptom
laboratori
find
includ
thrombocytopenia
evid
hemoconcentr
rise
urea
creatinin
level
hypernatremia
derang
liver
function
test
result
patholog
find
includ
necrosi
liver
lobul
cloudi
swell
fatti
degener
proxim
renal
tubul
often
petechia
organ
oliguria
appear
preren
due
hypovolemia
later
acut
tubular
necrosi
superven
present
effect
antivir
agent
yellow
fever
congocrimean
hemorrhag
fever
first
recogn
soviet
union
import
human
diseas
eastern
europ
asia
africa
tickborn
zoonot
viral
diseas
caus
cchf
viru
genu
nairoviru
famili
bunyavirida
sever
affect
patient
becom
stupor
comatos
day
ill
evid
hepat
renal
failur
shock
proteinuria
hematuria
often
present
diseas
fatal
case
recommend
ribavirin
treatment
choic
systemat
metaanalysi
show
chang
mortal
rate
random
control
trial
observ
studi
show
reduct
mortal
heavili
confound
random
control
trial
need
set
full
support
care
address
question
role
immunoglobulin
also
tri
casecontrol
trial
conduct
support
benefici
effect
rift
valley
fever
found
mani
area
subsaharan
africa
human
infect
follow
mosquito
bite
anim
exposur
infect
may
present
uncompl
febril
ill
muscl
ach
headach
patient
enceph
retin
vascul
occur
complic
small
proport
case
fulmin
often
fatal
hemorrhag
ill
occur
hematemesi
melena
epistaxi
evid
profound
dic
sever
hepat
derang
renal
failur
encephalopathi
often
present
despit
intens
care
mortal
high
virus
caus
hfr
belong
hantaviru
genu
bunyavirida
famili
hantavirus
distribut
worldwid
maintain
natur
chronic
infect
rodent
small
mammal
transmiss
human
aerosol
infecti
excreta
human
diseas
usual
occur
summer
among
rural
popul
exposur
rodentinfest
barn
grain
store
urban
transmiss
occur
howev
least
five
hantavirus
known
caus
hfr
hantaan
seoul
puumala
porogia
belgrad
virus
hfr
endem
belt
norway
west
sweden
finland
soviet
union
china
korea
japan
east
clinic
sever
hfr
vari
throughout
belt
clinic
entiti
includ
korean
hemorrhag
fever
nephropathia
epidemica
scandinavia
epidem
hemorrhag
fever
japan
china
gener
hfr
due
hantaan
porogia
belgrad
virus
sever
higher
mortal
due
puumala
viru
nephropathia
epidemica
seoul
viru
hantaan
predomin
far
east
porogia
belgrad
balkan
puumala
western
europ
seoul
worldwid
distribut
clinic
featur
diseas
vari
incub
period
day
although
hfr
occur
clinic
pictur
children
adult
incid
rate
antibodi
preval
rate
low
children
year
age
mild
case
indistinguish
febril
ill
sever
case
fever
headach
myalgia
abdomin
pain
dizzi
associ
develop
periorbit
edema
proteinuria
hematuria
often
conjunctiv
inject
pharyng
inject
petechia
epistaxi
gi
bleed
sever
affect
patient
develop
shock
renal
failur
diseas
usual
pass
five
phase
febril
hypotens
oligur
diuret
convalesc
laboratori
find
includ
anemia
lymphocytosi
thrombocytopenia
prolong
prothrombin
bleed
time
elev
level
fibrin
degrad
product
liver
enzym
level
elev
urea
creatinin
level
elev
oligur
phase
proteinuria
hematuria
consist
find
renal
histopatholog
find
interstiti
nephriti
promin
hemorrhag
renal
medullari
interstitium
renal
cortex
acut
tubular
necrosi
may
also
seen
immunohistochem
analysi
reveal
deposit
igg
gbm
mesangi
subendotheli
deposit
may
seen
electron
microscopi
recoveri
hantavirusassoci
diseas
gener
complet
although
chronic
renal
insuffici
rare
sequel
hfr
mildli
affect
patient
diseas
selflimit
spontan
recoveri
occur
howev
sever
case
shock
bleed
renal
failur
dialysi
intens
circulatori
support
may
requir
mortal
rate
vari
depend
strain
viru
rate
hemorrhag
fever
renal
syndrom
china
significantli
lower
milder
finnish
form
associ
puumala
viru
strain
ribavirin
activ
hantaan
virus
vitro
clinic
trial
indic
mortal
morbid
reduc
treatment
antivir
agent
administ
earli
cours
ill
dosag
mgkg
follow
mgkg
everi
h
day
mgkg
everi
h
day
use
lassa
fever
common
infect
west
africa
caus
arenaviru
usual
manifest
nonspecif
febril
ill
case
fulmin
hemorrhag
diseas
occur
sever
case
proteinuria
hematuria
usual
present
renal
failur
may
occur
ribavirin
effect
decreas
mortal
hemorrhag
fever
intens
hemodynam
support
correct
hemostat
derang
import
compon
therapi
junin
machupo
virus
agent
argentin
bolivian
hemorrhag
fever
respect
caus
hemorrhag
fever
promin
neurolog
featur
system
hemorrhag
featur
similar
lassa
fever
oliguria
shock
renal
failur
occur
sever
case
marburg
ebola
virus
associ
outbreak
nosocomi
transmit
hemorrhag
fever
west
africa
experienc
largest
outbreak
ebola
sever
thousand
case
liberia
sierra
leon
guinea
mortal
outbreak
high
affect
succumb
virus
caus
fulmin
hemorrhag
fever
onset
high
fever
headach
sore
throat
myalgia
profound
prostrat
erythemat
rash
trunk
follow
hemorrhag
conjunct
bleed
impair
renal
function
shock
respiratori
failur
renal
histopatholog
find
fatal
case
tubular
necrosi
fibrin
deposit
glomeruli
specif
treatment
disord
mani
ubiquit
viral
pathogen
infect
larg
proport
popul
annual
yet
rare
associ
renal
diseas
literatur
contain
scatter
report
acut
nephriti
infect
mani
virus
improv
molecular
diagnost
techniqu
led
recognit
virus
play
import
role
childhood
ill
exampl
human
metapneumoviru
boca
viru
latter
appear
greatest
clinic
impact
present
combin
virus
report
signific
direct
renal
patholog
virus
adenoviru
adenoviru
major
caus
hemorrhag
cystiti
commonli
implic
caus
hemorrhag
cystiti
boy
affect
often
girl
hematuria
persist
day
microscop
hematuria
dysuria
frequenc
may
occur
longer
period
adenoviru
type
usual
strain
isol
implic
caus
necrot
granulomat
tubulointerstiti
nephriti
transplant
recipi
primarili
affect
distal
nephron
preval
viremia
adult
transplant
recipi
estim
case
report
adult
report
treatment
immunosuppress
reduct
intraven
cidofovir
immunoglobulin
tri
prevent
reject
enteroviru
picornavirus
includ
enterovirus
link
acut
nephriti
aki
associ
rhabdomyolysi
coxsacki
b
viru
isol
urin
direct
infect
kidney
cell
support
vitro
work
demonstr
lytic
infect
human
podocyt
proxim
tubular
epitheli
cell
cultur
although
differ
strain
exhibit
variabl
degre
nephrotrop
renal
damag
vivo
may
direct
lytic
mechan
immunecomplex
basi
newborn
enterovirus
caus
fulmin
diseas
dic
shock
liver
failur
aki
may
occur
influenza
influenza
virus
import
infecti
agent
caus
pandem
last
two
decad
begin
last
decad
saw
outbreak
avian
flu
h
n
h
n
latter
part
decad
dealt
pandem
h
n
caus
flulik
ill
promin
respiratori
gastrointestin
symptom
renal
failur
develop
part
critic
ill
particular
renal
tubular
necrosi
recommend
standard
regimen
oseltamivir
use
treat
season
flu
use
treat
h
n
sever
ill
higher
dose
may
requir
oseltamivirresist
virus
report
southeast
asia
peramivir
zanamivir
also
use
treat
influenza
viru
subtyp
combin
antivir
drug
differ
mode
action
explor
improv
outcom
influenza
viremia
studi
still
underway
area
measl
viru
renal
involv
measl
viru
uncommon
although
measl
viru
cultur
kidney
fatal
case
acut
gn
report
follow
measl
evid
immun
deposit
contain
measl
viru
antigen
within
glomeruli
nephriti
gener
selflimit
mump
viru
mild
renal
involv
common
acut
phase
mump
infect
onethird
children
mump
abnorm
urinalysi
result
microscop
hematuria
proteinuria
mump
viru
may
isol
urin
first
day
ill
time
urinalysi
find
abnorm
plasma
creatinin
concentr
usual
remain
normal
despit
abnorm
urin
sediment
sever
case
unvaccin
children
result
fatal
interstiti
nephriti
interstiti
mononuclear
cell
infiltr
edema
focal
tubular
epitheli
cell
damag
renal
biopsi
specimen
adult
mump
nephriti
demonstr
mpgn
deposit
iga
igm
mump
viru
antigen
glomeruli
suggest
immunecomplexmedi
process
coronaviru
infect
mild
respiratori
infect
renal
involv
two
highli
pathogen
speci
describ
renal
cell
tropism
renal
effect
infect
requir
elucid
sarscov
sever
acut
respiratori
syndrom
sar
first
seen
south
china
caus
sar
coronaviru
sarscov
predominantli
caus
viral
pneumonia
diffus
alveolar
damag
consider
mortal
renal
effect
gener
signific
pathophysiolog
sar
acut
renal
impair
uncommon
sar
present
associ
high
mortal
neg
prognost
indic
surviv
case
report
document
rhabdomyolysi
associ
sar
aki
caus
aki
sarscov
found
kidney
tissu
postmortem
sarscov
enter
cell
via
angiotensinconvert
enzym
thought
invas
kidney
tissu
reflect
viru
tropism
express
kidney
cell
middl
east
region
coronaviru
merscov
merscov
caus
ill
clinic
similar
sarscov
discov
follow
outbreak
middl
east
new
case
continu
aris
mortal
highup
aki
note
number
case
report
vitro
studi
suggest
merscov
tropism
kidney
epitheli
cell
chronic
exposur
infecti
agent
major
factor
increas
preval
glomerular
diseas
develop
countri
malaria
bestdocu
parasit
infect
associ
glomerular
diseas
parasit
infect
includ
schistosomiasi
filariasi
leishmaniasi
possibl
helminth
infect
may
also
induc
nephriti
nephrosi
malaria
estim
caus
million
clinic
case
ill
one
million
death
year
associ
p
malaria
quartan
malaria
nephriti
well
known
temper
tropic
zone
sinc
end
nineteenth
centuri
epidemiolog
studi
earli
evid
role
plasmodium
malaria
glomerular
diseas
chronic
renal
diseas
major
caus
morbid
mortal
british
guiana
frequent
occurr
p
malaria
blood
patient
led
detail
epidemiolog
studi
implic
malaria
caus
nephrosi
erad
malaria
british
guiana
chronic
renal
diseas
ceas
major
caus
death
countri
link
malaria
nephrot
syndrom
strengthen
studi
west
africa
demonstr
high
preval
nephrot
syndrom
nigerian
popul
pattern
nephrot
syndrom
differ
temper
climat
older
peak
age
extrem
poor
prognosi
unusu
histolog
featur
incid
p
malaria
parasitemia
patient
nephrot
syndrom
nigeria
vastli
excess
occur
gener
popul
wherea
incid
plasmodium
falciparum
parasitemia
similar
gener
popul
age
distribut
nephrot
syndrom
also
close
parallel
p
malaria
infect
affect
patient
circul
immun
complex
immunoglobulin
complement
antigen
present
glomeruli
recogn
p
malariaespecif
antisera
patient
poorli
select
proteinuria
unrespons
treatment
steroid
immunosuppress
agent
characterist
lesion
quartan
nephropathi
capillari
wall
thicken
segment
glomerular
sclerosi
lead
progress
glomerular
chang
secondari
tubular
atrophi
cellular
prolifer
conspicu
absent
electron
microscopi
show
footprocess
fusion
thicken
basement
membran
increas
subendotheli
basement
membranelik
materi
immunofluoresc
studi
show
granular
deposit
immunoglobulin
complement
p
malaria
antigen
approxim
onethird
patient
prognosi
nephrot
syndrom
african
studi
poor
regardless
whether
histolog
find
typic
quartan
malaria
nephropathi
whether
p
malaria
parasitemia
implic
treatment
steroid
azathioprin
gener
ineffect
signific
proport
patient
progress
renal
failur
addit
histolog
pattern
term
quartan
malaria
nephropathi
p
malaria
infect
associ
varieti
form
histolog
appear
includ
prolif
gn
mgn
although
quartan
malaria
nephropathi
clearli
link
p
malaria
infect
nigeria
studi
region
africa
reveal
typic
histopatholog
find
describ
nigerian
studi
furthermor
quartan
malaria
nephropathi
may
seen
children
evid
p
malaria
infect
deposit
malaria
antigen
kidney
togeth
fact
antimalari
treatment
affect
progress
disord
rais
possibl
factor
malaria
might
involv
initi
perpetu
disord
view
pattern
childhood
renal
diseas
describ
last
centuri
may
longer
repres
current
situat
variabl
pattern
renal
diseas
throughout
africa
may
longer
reflect
domin
role
malari
glomerulopathi
rel
caus
role
tropic
infect
nephropathi
remain
unansw
question
like
number
differ
infecti
process
includ
malaria
hepat
b
schistosomiasi
perhap
parasit
infect
caus
chronic
persist
infect
often
occur
concurr
malaria
area
may
result
glomerular
injuri
rang
overlap
histopatholog
featur
renal
diseas
associ
plasmodium
falciparum
infect
plasmodium
falciparum
appear
much
less
like
caus
signific
glomerular
patholog
epidemiolog
studi
fail
show
clear
associ
parasitemia
nephrot
syndrom
wherea
renal
failur
appear
common
complic
sever
malaria
adult
seldom
occur
children
renal
biopsi
specimen
adult
patient
acut
p
falciparum
infect
proteinuria
hematuria
show
evid
glomerular
chang
includ
hypercellular
thicken
basement
membran
hyperplasia
hypertrophi
endotheli
cell
electron
microscopi
reveal
electrondens
deposit
subendotheli
paramesangi
area
deposit
igm
without
igg
local
mainli
mesangi
area
plasmodium
falciparum
antigen
demonstr
mesangi
area
along
capillari
wall
suggest
immunecomplex
gn
chang
gener
mild
transient
probabl
unrel
aki
may
complic
sever
p
falciparum
infect
heavili
parasit
erythrocyt
play
central
role
variou
patholog
factor
renal
failur
occur
sever
p
falciparum
malaria
usual
associ
acidosi
volum
deplet
acut
intravascular
hemolysi
heavi
parasit
infect
lead
acut
tubular
necrosi
recent
studi
confirm
import
role
volum
deplet
children
sever
plasmodium
falciparum
malaria
characterist
evid
tachycardia
tachypnea
poor
perfus
sever
case
hypotens
volum
expans
either
colloid
crystalloid
result
improv
hemodynam
indic
reduct
acidosi
howev
phase
random
trial
mlkg
albumin
salin
mainten
fluid
show
increas
mortal
patient
receiv
bolu
fluid
surpris
find
intens
debat
bolu
fluid
part
standard
resuscit
measur
children
critic
ill
worldwid
like
explan
advers
affect
fluid
bolu
deterior
pulmonari
neurolog
condit
associ
fluid
administr
trial
conduct
african
countri
ventil
support
avail
clear
find
extrapol
set
ventil
support
modern
intens
care
avail
howev
light
trial
routin
volum
expans
colloid
crystalloid
current
recommend
children
sever
malaria
set
intens
care
monitor
support
avail
term
blackwat
fever
refer
combin
sever
hemolysi
hemoglobinuria
renal
failur
common
start
twentieth
centuri
nonimmun
individu
receiv
intermitt
quinin
therapi
p
falciparum
malaria
blackwat
fever
becom
rare
sinc
quinin
replac
chloroquin
howev
diseas
reappear
increas
use
quinin
develop
chloroquineresist
organ
sinc
sever
case
describ
therapi
halofantrin
mefloquin
molecul
similar
quinin
amino
alcohol
famili
renal
failur
gener
occur
context
sever
hemolyt
anemia
hemoglobinuria
jaundic
pathophysiolog
disord
unclear
howev
appear
doubl
sensit
red
blood
cell
p
falciparum
amino
alcohol
necessari
provok
hemolysi
histopatholog
find
includ
swell
vacuol
proxim
tubul
necrosi
degener
distal
tubul
hemoglobin
deposit
renal
tubul
recent
studi
indic
better
outcom
earlier
initi
intens
care
dialysi
combin
necessari
chang
antimalari
medic
schistosomiasi
affect
million
peopl
live
endem
area
asia
africa
south
america
infect
usual
acquir
childhood
repeat
infect
occur
throughout
life
schistosoma
japonicum
found
orient
wherea
schistosoma
haematobium
occur
throughout
africa
middl
east
area
southwest
asia
schistosoma
mansoni
widespread
africa
south
america
southwest
asia
human
infect
begin
cercari
form
invad
skin
develop
schistosomula
move
lung
via
lymphat
blood
migrat
liver
matur
intrahepat
portal
venul
malefemal
pair
take
place
adult
worm
pair
migrat
final
rest
siteth
venul
mesenter
venou
system
larg
intestin
mansoni
venul
urinari
tract
haematobium
femal
releas
larg
number
egg
may
remain
embed
tissu
embol
liver
lung
pass
fece
urin
clinic
manifest
may
occur
stage
infect
cercari
invas
may
caus
intens
itchi
papular
rash
katayama
fever
acut
serum
sicknesslik
ill
occur
sever
week
infect
egg
deposit
tissu
deposit
egg
tissu
result
inflamm
intestin
fibrosi
liver
portal
hypertens
haematobium
chronic
inflamm
fibrosi
uret
bladder
may
lead
obstruct
uropathi
renal
manifest
schistosomiasi
occur
commonli
mansoni
infect
schistosom
nephropathi
usual
present
symptom
includ
granulomat
inflamm
uret
bladder
glomerular
diseas
probabl
immunecomplex
basi
may
also
occur
renal
diseas
usual
occur
older
children
young
adult
longterm
infect
seriou
diseas
may
also
occur
young
children
isol
case
report
young
children
present
nephrot
syndrom
secondari
schistosoma
haematobium
infect
directli
caus
membranoprolif
glomerulonephr
earli
renal
tract
manifest
schistosomiasi
suprapub
discomfort
frequenc
dysuria
termin
hematuria
sever
case
evid
urinari
obstruct
appear
poor
urinari
stream
strain
micturit
feel
incomplet
bladder
empti
constant
urg
urin
may
sever
disabl
symptom
fibrosi
inflamm
uret
urethra
bladder
may
follow
calcif
may
result
hydrouret
hydronephrosi
bladder
neck
obstruct
renal
failur
may
ultim
develop
suspicion
squamou
cell
carcinoma
bladder
may
link
chronic
infect
inflammatori
process
secondari
bacteri
infect
common
within
obstruct
inflam
urinari
tract
hepatosplen
form
mansoni
infect
may
accompani
glomerulopathi
case
manifest
major
nephrot
syndrom
histopatholog
find
includ
mesangioprolif
gn
focal
segment
glomerulosclerosi
mesangiocapillari
gn
mgn
focal
segment
hyalinosi
immun
complex
may
detect
circul
patient
glomerular
granular
deposit
igm
schistosom
antigen
seen
immunofluoresc
usual
schistosomaspecif
nephropathi
progress
diseas
influenc
antiparasit
immunosuppress
therapi
diagnosi
confirm
detect
schistosomula
egg
fece
urin
biopsi
specimen
egg
shed
urin
diurnal
rhythm
urin
collect
pm
use
urinari
sediment
obtain
centrifug
filtrat
nuclepor
membran
examin
case
studi
urin
fece
yield
neg
result
patient
diagnosi
suspect
rectal
biopsi
specimen
taken
approxim
cm
anu
high
diagnost
yield
mansoni
haematobium
infect
biopsi
liver
bladder
may
requir
establish
diagnosi
antibodi
indic
previou
infect
detect
use
enzymelink
immunosorb
assay
radioimmunoassay
test
sensit
lack
specif
may
differenti
past
exposur
current
infect
praziquantel
drug
choic
treatment
schistosomiasi
singl
oral
dose
mgkg
effect
haematobium
mansoni
infect
usual
well
toler
altern
drug
mansoni
infect
oxamniquin
complet
remiss
urinari
symptom
may
occur
renal
diseas
short
durat
late
diseas
extens
fibrosi
scar
calcif
obstruct
uropathi
renal
failur
may
persist
infect
erad
viscer
leishmaniasi
chronic
protozoon
infect
character
fever
hepatosplenomegali
anemia
leukopenia
hyperglobulinemia
proteinuria
andor
microscop
hematuria
pyuria
report
patient
viscer
leishmaniasi
aki
associ
interstiti
nephriti
also
report
renal
histolog
analysi
patient
viscer
leishmaniasi
reveal
glomerular
chang
featur
mesangi
prolif
gn
focal
prolif
gn
gener
interstiti
nephriti
interstiti
edema
mononuclear
cell
infiltr
focal
tubular
degener
immunofluoresc
reveal
deposit
igg
igm
within
glomeruli
well
electrondens
deposit
basement
membran
mesangium
electron
microscopi
circul
immun
complex
togeth
immunoglobulin
complement
deposit
glomeruli
suggest
immunecomplex
caus
renal
diseas
leishmaniasi
usual
mild
may
resolv
treatment
infect
renal
dysfunct
may
associ
treatment
viscer
leishmaniasi
antimoni
compound
proteinuria
common
filari
hyperendem
region
west
africa
nonfilari
area
renal
histolog
analysi
shown
varieti
differ
histopatholog
appear
common
diffus
mesangi
prolif
gn
deposit
glomeruli
renal
biopsi
specimen
also
demonstr
larg
number
eosinophil
glomeruli
microfilaria
may
seen
lumen
glomerular
capillari
filari
antigen
detect
within
immun
deposit
within
glomeruli
lymphat
filariasi
also
associ
chyluria
echinococcu
granulosu
caus
chronic
cyst
within
varieti
organ
addit
nephrot
syndrom
associ
hydatid
diseas
report
membran
nephropathi
minim
chang
lesion
mesangiocapillari
gn
describ
associ
hydatid
diseas
immunofluoresc
reveal
deposit
immunoglobulin
complement
hydatid
antigen
within
glomeruli
remiss
nephrot
syndrom
report
treatment
antiparasit
agent
albendazol
nephrot
syndrom
occasion
report
manifest
congenit
toxoplasmosi
dissemin
previous
latent
toxoplasma
infect
patient
undergo
treatment
immunosuppress
drug
increasingli
recogn
recent
year
reactiv
toxoplasmosi
progress
recent
acquir
primari
infect
consid
patient
undergo
renal
transplant
immunotherapi
renal
diseas
develop
unexplain
inflamm
organ
fungal
infect
kidney
urinari
tract
occur
commonli
part
system
fungal
infect
patient
underli
immunodefici
focal
urinari
tract
infect
patient
obstruct
lesion
result
indwel
cathet
although
candid
infect
common
fungal
infect
immunocompromis
nonimmunocompromis
host
virtual
fungal
pathogen
may
invad
renal
tract
sever
immunocompromis
urinari
infect
candida
albican
commonli
compon
system
candidiasi
patient
sever
immunocompromis
system
candidiasi
also
seen
prematur
term
infant
perinat
acquir
invas
candidiasi
present
usual
system
sepsi
fever
hypothermia
hepatosplenomegali
erythemat
rash
thrombocytopenia
system
candidiasi
may
seen
ophthalmolog
investig
microemboli
retina
first
clue
underli
diagnosi
may
presenc
yeast
urin
candid
involv
urinari
tract
may
affect
structur
includ
glomeruli
tubul
collect
system
uret
bladder
microabscess
may
form
within
renal
parenchyma
larg
ball
fungi
may
complet
obstruct
urinari
tract
level
aki
caus
system
candidiasi
obstruct
renal
tract
fungal
hypha
wellrecogn
complic
system
candid
infect
indwel
cathet
form
nidu
persist
infect
remov
success
treatment
nonobstruct
bilater
renal
fungal
ball
fluconazol
either
alon
combin
liposom
amphotericin
b
report
presenc
obstruct
howev
percutan
nephrostomi
reliev
obstruct
anterograd
amphotericin
b
irrig
coupl
system
antifung
therapi
mainstay
treatment
amphotericin
b
effect
antifung
agent
excret
urin
local
irrig
via
nephrostomi
provid
good
result
howev
treatment
urinari
tract
candidiasi
usual
combin
fluconazol
excret
high
concentr
urin
treatment
requir
week
month
ensur
complet
elimin
fungu
ultim
outcom
larg
depend
whether
perman
defect
immun
levin
et
al
first
describ
hemorrhag
shock
encephalopathi
appear
distinct
previous
recogn
pediatr
disord
case
subsequ
report
sever
center
unit
kingdom
europ
israel
unit
state
australia
syndrom
recogn
distinct
sever
childhood
disord
hemorrhag
shock
encephalopathi
usual
affect
infant
first
year
life
peak
onset
month
age
prodrom
ill
fever
irrit
diarrhea
upper
respiratori
infect
occur
day
onset
twothird
case
affect
infant
develop
profound
shock
coma
convuls
bleed
evid
dic
diarrhea
oliguria
laboratori
find
includ
acidosi
fall
hemoglobin
platelet
level
elev
urea
creatinin
level
elev
level
hepat
transaminas
despit
vigor
intens
care
prognosi
poor
affect
infant
die
left
sever
neurolog
damag
small
number
patient
report
surviv
without
residu
sequela
renal
impair
appear
larg
preren
origin
aggress
volum
replac
treatment
shock
result
improv
renal
perfus
rapid
improv
renal
function
usual
observ
patient
profound
shock
unrespons
initi
resuscit
vasomotor
nephropathi
superven
dialysi
may
requir
myoglobinuria
associ
hemorrhag
shock
encephalopathi
report
follow
descript
mucocutan
lymph
node
syndrom
kawasaki
kawasaki
diseas
kd
recogn
common
seriou
childhood
ill
worldwid
distribut
although
etiolog
remain
unknown
epidemiolog
featur
clearli
suggest
infect
caus
diseas
occur
epidem
wavelik
spread
demonstr
outbreak
japan
see
chap
renal
involv
children
vascul
main
complic
kd
develop
vascul
affect
smalland
mediums
muscular
arteri
although
coronari
arteri
commonli
affect
sever
case
vascul
widespread
affect
axillari
femor
carotid
renal
mesenter
arteri
renal
involv
kd
common
proteinuria
steril
pyuria
commonli
detect
acut
diseas
sever
kidney
involv
less
common
report
broad
spectrum
kidney
involv
includ
acut
kidney
injuri
interstiti
nephriti
immunecomplex
nephriti
nephrot
syndrom
hemolyt
urem
syndrom
vascul
kd
involv
neutrophil
lymphocyt
influx
vessel
wall
destruct
intima
media
involv
extraren
intraren
vasculatur
result
area
infarct
hypertens
report
histolog
featur
kd
patient
sever
form
renal
involv
includ
interstiti
infiltr
leukocyt
immunecomplex
nephriti
swell
endotheli
mesangi
cell
dens
deposit
vascul
treatment
kd
aim
rapid
cessat
inflammatori
process
patient
respond
intraven
immunoglobulin
addit
antiinflammatori
agent
includ
steroid
antitnf
agent
anakinra
cyclosporin
report
benefici
xgp
chronic
inflammatori
disord
kidney
invad
parenchyma
character
granulomat
inflamm
giant
cell
foami
histiocyt
unilater
caus
urinari
tract
obstruct
infect
nephrolithiasi
diabet
andor
immunocompromis
rare
children
occur
typic
affect
boy
year
age
case
seri
quinn
et
al
show
incid
surgic
proven
chronic
pyelonephr
case
report
associ
renal
vein
thrombi
present
anorexia
weight
loss
fever
chill
dull
persist
flank
pain
occur
renal
infect
e
coli
proteu
pseudomona
infect
implic
xgp
also
refer
pseudotumor
radiolog
clinic
indistinguish
renal
carcinoma
treatment
surgic
